Category: Health

  • MIL-OSI USA: Attorney General James Secures Prison Sentence for Serial Health Care Fraudster

    Source: US State of New York

    NEW YORK – New York Attorney General Letitia James today announced the sentencing of Imran Shams, 66, of California, to eight and one third to twenty-five years in state prison for his role in a scheme that wrongfully billed Medicaid millions of dollars for fraudulent medical testing services. On March 6, 2020, Shams pleaded guilty to Grand Larceny in the First and Second Degrees and agreed to pay restitution of $7 million. Shams is currently serving a 13-year federal prison sentence following convictions in the United States District Courts for the Eastern District of New York and the Central District of California for conduct related to his New York scheme, as well as other health care fraud schemes.

    “When criminal organizations abuse our health care system, the most vulnerable patients suffer,” said Attorney General James. “Imram Shams and his accomplices ran a despicable scheme that used vulnerable New Yorkers to steal millions of dollars meant to provide care for low-income patients. My office will continue to go after those who try to profit by undermining the Medicaid program and bring bad actors to justice.”

    Shams’ sentencing is the culmination of a multi-year investigation and prosecution of the illegal activity of Multi-Specialty, a fraudulent medical clinic secretly owned by Shams, who was banned from billing Medicaid as a provider due to a previous health care fraud conviction. Multi-Specialty illegally paid Medicaid recipients a kickback of $20 to $50 to enter the clinic and submit to unnecessary and usually fraudulent evaluations and tests. These were often administered by untrained and incompetent individuals recruited to dress like health care professionals in order to lend an appearance of legitimacy to the fraud.

    Soliciting Medicaid recipients by offering to pay them to accept medical services paid for by Medicaid is unlawful under state and federal law. After bribing recipients to enter his clinic, Shams used licensed health care providers complicit in the scheme to submit fraudulent claims to Medicaid and to Medicaid-funded Managed Care Organizations (MCOs) for unnecessary or nonexistent services. Shams also received millions of dollars in kickbacks for exclusively referring patients for diagnostic testing, regardless of medical need, to companies owned by other participants in the scheme, Tea Kaganovich and Ramazi Mitaishvili, both of Brooklyn.

    Shams was sentenced today to eight and one third to twenty-five years in prison, to run concurrent with his federal sentence, by Judge Michele Rodney of the New York County Supreme Court, and is the last defendant to be sentenced in this scheme. His sentence follows the convictions and sentencings of Kaganovich and Mitaishvili on charges of Grand Larceny in the First Degree. Both received a sentence of one and a half to four and a half years in state prison in November 2023. In addition, a radiologist complicit in the scheme, Bernard Bentley of East Hampton, New York received a sentence of three years of probation on charges of Grand Larceny in the Second Degree for his role in fraudulently billing Medicaid over eight million dollars for fraudulent diagnostic testing services.

    Kaganovich and Mitaishvili were prosecuted in a related criminal case in the Eastern District of New York, and as part of that case, were ordered to pay over $18 million of restitution to the New York Medicaid Fraud Restitution Fund, and it is expected that more than seven million dollars in assets seized from those defendants as part of the federal case will be remitted to New York.

    The Attorney General would like to thank the New York State Office of the Medicaid Inspector General (OMIG), the U.S. Department of Justice Medicare Strike Force, which operates from the U.S. Attorney’s Office, Eastern District of New York; the United States Department of Health and Human Services, Office of the Inspector General (HHS OIG); the New York City Human Resources Administration, Medicaid Provider Investigations and Audit Unit, and HealthFirst for their assistance and cooperation in this investigation. 

    Senior Detective Stanislav Tabakov investigated the case with the assistance of Detective Supervisor Dominick DiGennaro. Senior Auditor Investigator Lisandra Defex conducted the financial analysis with the assistance of MFCU New York City Regional Chief Auditor Investigator Thomasina Smith and Deputy Regional Chief Auditor Jonathan Romano.

    Special Assistant Attorney General Chase Ruddy prosecuted the criminal case under the supervision of NYC Regional Director Twan V. Bounds. Deputy Chief of MFCU’s Civil Enforcement Division, Konrad F. Payne, negotiated monetary settlements attendant to each defendant’s guilty pleas that recovered millions of dollars for the state. Alee Scott is the Chief of MFCU’s Civil Enforcement Division. Thomas O’Hanlon is MFCU’s Chief of Criminal Investigations. MFCU is led by Director Amy Held and Assistant Deputy Attorney General Paul Mahoney. The Division of Criminal Justice is led by Chief Deputy Attorney General José Maldonado under the oversight of First Deputy Attorney General Jennifer Levy.

    MFCU defends the public by addressing Medicaid provider fraud and protecting nursing home residents from abuse and neglect. If an individual believes they have information about Medicaid provider fraud or about an incident of abuse or neglect of a nursing home resident, they can file a confidential complaint online or call the MFCU hotline at (800) 771-7755. If the situation is an emergency, please call 911.

    New York MFCU’s total funding for federal fiscal year (FY) 2025 is $70,502,916. Of that total, 75 percent, or $52,877,188, is funded from the U.S. Department of Health and Human Services. The remaining 25 percent, totaling $17,625,728 for FY 2025, is funded by New York State.

    MIL OSI USA News

  • MIL-OSI Canada: Company penalized for workplace injuries

    Source: Government of Canada regional news (2)

    MIL OSI Canada News

  • MIL-OSI New Zealand: Incidents on South-Western Motorway and Southern Motorway

    Source: New Zealand Police (District News)

    Motorists on Auckland’s South Western and Southern Motorway network may experience delays this morning, after two fatal incidents on the network in the early hours of this morning.

    Emergency services attended an incident on South Western Motorway, Mount Roskil reported at around 1am. A person had entered the motorway on foot and had been struck by a vehicle. The person died at the scene, no other injuries are reported. Enquiries into the circumstances of the incident are ongoing.

    Emergency services attended a crash involving a single vehicle on Southern Motorway, Otara, reported at around 2.20am. One person died at the scene, two people were transported to Auckland Hospital in a critical condition and two other people were transported to Middlemore Hospital in a serious condition. Enquiries into the circumstances of the incident are ongoing.

    ENDS

    Issued by Police Media Centre

    MIL OSI New Zealand News

  • MIL-OSI: Erin Lassel Joins First American Bank as Associate General Counsel

    Source: GlobeNewswire (MIL-OSI)

    MIAMI, Feb. 06, 2025 (GLOBE NEWSWIRE) — First American Bank is proud to announce that Erin Lassel has joined the bank as Associate General Counsel. With over 10 years of experience in commercial real estate law, Erin will play a pivotal role in advancing the bank’s strategic initiatives, joining the broader Legal team that supports the bank’s diverse markets across Illinois, Florida, Wisconsin, and beyond.

    As the bank grows its presence in South Florida, Erin’s legal expertise will be instrumental in addressing complex challenges and ensuring the bank’s operations align with the evolving needs of its regional, national, and global customer base.

    “Joining First American Bank is an exciting opportunity to contribute to the bank’s commitment to excellence and customer-focused solutions,” said Erin Lassel, Associate General Counsel. “I look forward to leveraging my legal expertise to help shape the future of the bank, support its growth, and champion the delivery of innovative financial services to our customers.”

    Christine Childers, Deputy General Counsel at First American Bank, added, “Erin’s extensive experience in commercial real estate law and her leadership skills make her a strong fit for our team. Her expertise will be invaluable as we expand our South Florida operations and strengthen our market position.”

    Before joining First American Bank, Erin was a partner at Katz Barron in Coral Gables and Fort Lauderdale, where she represented clients across Florida in real estate and business transactions. She earned her Juris Doctor (J.D.) magna cum laude from Florida International University, ranking in the top 10% of her class, and served as Executive Symposium Editor for the Florida International University Law Review. Erin also holds a B.A. in Accounting, summa cum laude, from the University of Miami.

    “We are pleased to welcome Erin to the team,” said Brian Hagan, Florida Market President at First American Bank. “Her distinguished legal background, combined with her leadership and knowledge of the South Florida market, makes her an invaluable addition as we continue to expand our footprint in the region and build on our reputation for excellence.”

    First American Bank is a Member FDIC.

    Contact:
    Teresa Lee 
    305-631-6400 
    tlee@firstambank.com

    The MIL Network

  • MIL-OSI United Kingdom: Flu and COVID-19 surveillance reports bulletin 2025

    Source: United Kingdom – Executive Government & Departments

    This bulletin (formally Weekly Winter Briefing) brings together the latest surveillance data, along with the latest public health advice for flu, COVID-19, RSV and other viruses common in winter.

    Latest update

    Thursday 6 February 2025

    In week 5:

    • influenza (flu) activity overall decreased across most indicators and was at medium activity levels – there continues to be an increase in influenza B across some indicators
    • COVID-19 activity remained stable across most indicators and was at baseline activity levels
    • respiratory syncytial virus (RSV) activity decreased across most indicators and was circulating at low levels overall

    For more information see the flu, COVID-19 and RSV surveillance report and norovirus surveillance report.

    Flu surveillance data

    In week 5:

    • flu activity overall decreased across most indicators and was at medium activity levels – there continues to be an increase in influenza B across some indicators
    • flu positivity decreased with a weekly mean positivity rate of 14%, compared to 15.6% in the previous week, this is based on a percentage of people who test positive among those with symptoms tested
    • overall, flu hospitalisations decreased slightly to 6.40 per 100,000 population, compared with 7.00 per 100,000 in the previous week
    • in week 5, the weekly influenza-like illnesses (ILI) General Practice (GP) consultation rate decreased to 13.9 per 100,000 compared with 15.4 per 100,000 in the previous week
    • reporting of the weekly influenza vaccine uptake for the 2024 to 2025 season concluded last week
    • up to the end of week 4 (week ending 26 January 2025), vaccine uptake was 39.7% for those under 65 years in a clinical risk group, 34.8% in all pregnant women and 74.6% for all those aged 65 years and over
    • uptake was 41.4% for children aged 2 years of age and 43.2% for children aged 3 years of age

    COVID-19 surveillance data

    In week 5:

    • COVID-19 activity remained stable across most indicators and was at baseline activity levels
    • COVID-19 positivity in hospital settings remained stable with a weekly mean positivity rate of 2.5% compared with 2.4% in the previous week
    • COVID-19 hospitalisations remained stable at 1.15 per 100,000 compared to 1.12 per 100,000 in the previous week
    • COVID-19 ICU admissions remained stable at 0.03 per 100,000 compared with 0.03 per 100,000 in the previous week
    • there were 9 COVID-19 acute respiratory incidents reported in week 4
    • the highest hospital admission rate was in the North-West, which increased to 1.79 per 100,00 compared with 1.36 per 100,000 in the previous week
    • those aged 85 years and over had the highest hospital admission rate, which increased to 13.84 per 100,000 compared with 11.78 per 100,000 in the previous week  
    • up to the end of week 5 (week ending 2 February 2025), 23.6% of those under 65 years in a clinical risk group and 59.3% of all people aged over 65 years old, who are living and resident in England had been vaccinated

    Respiratory syncytial virus (RSV) surveillance data

    In week 5:

    • respiratory syncytial virus (RSV) activity decreased across most indicators and was circulating at low levels overall
    • emergency department attendances for acute bronchiolitis remained stable
    • RSV positivity decreased to 2.5% compared with 3.9% in the previous week
    • overall, hospital admissions decreased to 1.06 per 100,000 compared with 1.42 per 100,000 in the previous week

    UKHSA monitors Human metapneumovirus (hMPV) detections in patients seen in GP practices or tested by hospital laboratories and reports on this in the weekly surveillance report.

    hMPV is a common respiratory infection in winter and current levels are expected at this time of year. Infections are usually mild, causing symptoms of a common cold. Most people have had hMPV by the time they are five years old and catch it again throughout their lives. In week 5, hMPV laboratory test positivity increased slightly to 4.2% from 3.8% in the previous week.

    Dr Alexander Allen, Consultant Epidemiologist at UKHSA, said: 

    We’re pleased to see that the downward trend in flu activity has continued into this week.

    If you have already had your flu vaccine this season, you can be reassured that the vaccine offers the best defence and protects against multiple strains. The predominant circulating flu strain continues to be A H1N1 clade 5a.2a. and the flu vaccine is well matched.

    If you’re eligible and haven’t yet had your flu vaccine, it’s important that you take this offer up if available through local services. This includes anyone recently pregnant or newly diagnosed as in an eligible clinical risk group.

    If you have symptoms of flu or COVID-19 such as a high temperature, cough and feeling tired and achy, try to limit your contact with others, especially those who are vulnerable. If you have symptoms and need to leave the house, our advice remains that you should consider wearing a face covering. Washing hands regularly and using and disposing tissues in bins can reduce the spread of respiratory illnesses, as can ensuring that indoor areas are well ventilated.

    Norovirus surveillance data

    In week 4:

    • norovirus reports in the 2-week period between 13 January 2025 to 26 January 2025 were 15% higher than the previous 2-week period
    • the total number of reports was 114.5% higher than the 5-season average for the same 2-week period – reporting remained highest in adults aged 65 years and over
    • rotavirus reporting increased in recent weeks but was within expected levels during the 2-week period of weeks 3 and 4 of 2025
    • the number of norovirus outbreaks reported to the Hospital Norovirus Outbreak Reporting System (HNORS) since the start of the 2024/2025 season is 15.8% higher than the 5-season average
    • while some of the increased reporting may be attributable to the increased use of PCR multiplex technology (capable of detecting multiple gastrointestinal pathogens in one test), it is likely that the emergence of an unusual norovirus genotype, GII.17, as well as changes in the epidemiology following the COVID-19 pandemic and other factors are contributing to the observed rise
    • during the 2024/2025 season to date, the majority (90.7%) of samples characterised were norovirus genogroup 2 (GII), of which the most frequently identified genotype was GII.17 (55.4%), an increase of this genotype has also been observed in other counties during 2024 and is being closely monitored – at present there is no indication it leads to more severe illness (note: it isn’t accurate to refer to GII.17 as ‘Kawasaki’ and this term is causing confusion with Kawasaki Disease, which is an unrelated disease)
    • laboratory reports represent just a small proportion of total norovirus cases and it has been estimated that for every case of norovirus reported to national surveillance in the UK there are about 288 in the community that go unreported, representing an annual burden of around 3 million cases
    • norovirus symptoms include nausea, vomiting and diarrhoea but can also include a high temperature, abdominal pain and aching limbs
    • norovirus infections can cause dehydration, especially in vulnerable groups such as young children and older or immunocompromised people, so if you do get ill it is important to drink plenty of fluids during that time

    Amy Douglas, Epidemiologist at UKHSA said:

    Norovirus cases are way above what we would usually see at this time of year and outbreaks in hospitals continue to rise. Just because you’ve had norovirus doesn’t mean you won’t get it again.

    It’s really important that if you have diarrhoea and vomiting, you take steps to avoid passing the infection on, including not  visiting people in hospitals and care homes.

    Do not return to work, school or nursery until 48 hours after your symptoms have stopped and don’t prepare food for others in that time either. This is because you can still pass on the virus in the days after you stop being sick.

    Washing your hands with soap and warm water and using bleach-based products to clean surfaces will also help stop infections from spreading. Alcohol gels do not kill norovirus so don’t rely on these alone.

    Norovirus infections can cause dehydration, especially in vulnerable groups such as young children and older or immunocompromised people, so if you do get ill it is important to drink plenty of fluids during that time.

    Washing your hands with soap and warm water and using bleach-based products to clean surfaces will also help stop infections from spreading. Alcohol gels do not kill norovirus so don’t rely on these alone.

    Previous

    Thursday 30 January 2025

    This bulletin (formally Weekly Winter Briefing) brings together the latest surveillance data, along with the latest public health advice for flu, COVID-19, RSV and other viruses common in winter.

    In week 4:

    • influenza activity overall decreased across most indicators and was at medium activity levels – there continues to be an increase in influenza B across some indicators
    • COVID-19 activity remained stable across most indicators and was at baseline activity levels
    • respiratory syncytial virus (RSV) activity showed a mixed picture and was circulating at low levels overall

    For more information see the flu, COVID-19 and RSV surveillance report and norovirus surveillance report.

    Flu surveillance data for week 4

    • Flu activity overall decreased across most indicators and was at medium activity levels. There continues to be an increase in influenza B across some indicators.
    • Flu positivity decreased with a weekly mean positivity rate of 15.6%, compared to 27.4% in the previous week. This is based on a percentage of people who test positive among those with symptoms tested.
    • Overall, flu hospitalisations decreased to 7.13 per 100,000 population, compared with 8.51 per 100,000 in the previous week.
    • For primary care surveillance, due to a technical issue in processing the data, the influenza-like-illness (ILI) consultations indicator has not been updated this week. In week 3, the weekly ILI General Practice (GP) consultation rate decreased to 17 per 100,000 compared with 23.1 per 100,000 in the previous week.
    • Up to the end of week 4 (week ending 26 January 2025), vaccine uptake was 39.7% for those under 65 years in a clinical risk group, 34.8% in all pregnant women and 74.6% for all those aged 65 years and over. Uptake was 41.4% for children aged 2 years of age and 43.2% for children aged 3 years of age.

    COVID-19 surveillance data for week 4

    • COVID-19 activity remained stable across most indicators and was at baseline activity levels.
    • COVID-19 positivity in hospital settings remained stable with a weekly mean positivity rate of 2.4% compared with 2.4% in the previous week.
    • COVID-19 hospitalisations decreased to 1.13 per 100,000 compared to 1.33 per 100,000 in the previous week.
    • COVID-19 ICU admissions remained stable at 0.03 per 100,000 compared with 0.05 per 100,000 in the previous week.
    • There were 11 COVID-19 acute respiratory incidents reported in week 4.
    • The highest hospital admission rate was in the North-East, which decreased to 2.37 per 100,00 compared with 2.74 per 100,000 in the previous week. 
    • Those aged 85 years and over had the highest hospital admission rate, which decreased to 11.86 per 100,000 compared with 15.14 per 100,000 in the previous week.  
    • Up to the end of week 4 (week ending 26 January 2025), 23.6% of those under 65 years in a clinical risk group and 59.3% of all people aged over 65 years old, who are living and resident in England had been vaccinated.

    Respiratory syncytial virus (RSV) surveillance data for week 4

    • Respiratory syncytial virus (RSV) activity showed a mixed picture and was circulating at low levels overall.
    • Emergency department attendances for acute bronchiolitis remained stable.
    • RSV positivity decreased slightly to 3.8% compared with 4.2% in the previous week.
    • Overall, hospital admissions increased to 1.42 per 100,000 compared with 1.20 per 100,000 in the previous week.
    • UKHSA monitors Human metapneumovirus (hMPV) detections in patients seen in GP practices or tested by hospital laboratories and reports on this in the weekly surveillance report. hMPV is a common respiratory infection in winter and current levels are expected at this time of year. Infections are usually mild, causing symptoms of a common cold and most people have had hMPV by the time they are five years old and catch it again throughout their lives. In week 4, hMPV laboratory test positivity decreased to 3.9% from 4.5% in the previous week.

    Dr Alexander Allen, Consultant Epidemiologist at UKHSA, said: 

    We’re continuing to see flu activity decrease, which is really promising at this stage in the season. People are still reminded to take protective measures to ensure we keep cases down as we have seen a recent increase in cases of influenza B amongst children, although this is to be expected at this time of year.

    The vaccine offers the best defence against flu and protects against multiple flu strains, including B strains. The predominant circulating flu strain continues to be A H1N1 clade 5a.2a. Analysis by UKHSA laboratory scientists shows that the H1N1 component of the flu vaccine is well matched.

    If you’re eligible and have not yet had your flu vaccine, it’s important that you take this offer up if available through local services. This includes anyone recently pregnant or newly diagnosed as in an eligible clinical risk group.

    If you have symptoms of flu or COVID-19 such as a high temperature, cough and feeling tired and achy, try to limit your contact with others, especially those who are vulnerable. If you have symptoms and need to leave the house, our advice remains that you should consider wearing a face covering. Washing hands regularly and using and disposing tissues in bins can reduce the spread of respiratory illnesses, as can ensuring that indoor areas are well ventilated.

    Norovirus surveillance data for week 3

    • Norovirus reports in the 2-week period between 6 January 2025 to 19 January 2025 were 18.3% higher than the previous 2-week period. The total number of reports was 113.3% higher than the 5-season average for the same 2-week period. Reporting remained highest in adults aged 65 years and over.
    • Rotavirus reporting has started to increase again in recent weeks but was within expected levels during the 2-week period of weeks 2 and 3 of 2025.
    • The number of norovirus outbreaks reported to the Hospital Norovirus Outbreak Reporting System (HNORS) since the start of the 2024/2025 season is 14.3% higher than the 5-season average.
    • While some of the increased reporting may be attributable to the increased use of PCR multiplex technology (capable of detecting multiple gastrointestinal pathogens in one test), it is likely that the emergence of an unusual norovirus genotype, GII.17, as well as changes in the epidemiology following the COVID-19 pandemic and other factors are contributing to the observed rise.
    • During the 2024/2025 season to date, the majority (90.4%) of samples characterised were norovirus genogroup 2 (GII), of which the most frequently identified genotype was GII.17 (56.3%), an increase of this genotype has also been observed in other counties during 2024 and is being closely monitored — at present there is no indication it leads to more severe illness (note: it is not accurate to refer to GII.17 as ‘Kawasaki’ and this term is causing confusion with Kawasaki Disease, which is an unrelated disease)
    • Laboratory reports represent just a small proportion of total norovirus cases and it has been estimated that for every case of norovirus reported to national surveillance in the UK there are about 288 in the community that go unreported, representing an annual burden of around 3 million cases.
    • Norovirus symptoms include nausea, vomiting and diarrhoea but can also include a high temperature, abdominal pain and aching limbs. Norovirus infections can cause dehydration, especially in vulnerable groups such as young children and older or immunocompromised people, so if you do get ill it is important to drink plenty of fluids during that time.

    Amy Douglas, Epidemiologist at UKHSA said:

    Norovirus cases are over double what we would usually see at this time of year. This isn’t just unpleasant for those affected – it’s having a big impact on hospitals and care homes.

    It’s really important that if you have diarrhoea and vomiting, you take steps to avoid passing the infection on. Please avoid visiting people in hospitals and care homes to prevent passing on the infection in these settings.

    Do not return to work, school or nursery until 48 hours after your symptoms have stopped and don’t prepare food for others in that time either. This is because you can still pass on the virus in the days after you stop being sick.

    Washing your hands with soap and warm water and using bleach-based products to clean surfaces will also help stop infections from spreading. Alcohol gels do not kill norovirus so do not rely on these alone.

    Previous

    Thursday 23 January 2025

    This bulletin (formally Weekly Winter Briefing) brings together the latest surveillance data, along with the latest public health advice for flu, COVID-19, RSV and other viruses common in winter.

    In week 3:

    • influenza activity overall decreased across most indicators and was at medium activity levels; however, laboratory surveillance indicated an increase in influenza B
    • COVID-19 activity remained stable across most indicators and was at baseline activity levels
    • respiratory syncytial virus (RSV) activity decreased across most indicators and was circulating at low levels of activity

    For more information see the flu, COVID-19 and RSV surveillance report and norovirus surveillance report.

    Flu surveillance data for week 3

    • Flu activity overall decreased across most indicators and was at medium activity levels. However, laboratory surveillance indicated an increase in influenza B.
    • Flu positivity decreased with a weekly mean positivity rate of 17.5%, compared to 21.1% in the previous week. This is based on a percentage of people who test positive among those with symptoms tested.
    • Overall, flu hospitalisations decreased to 8.41 per 100,000 population, compared with 9.92 per 100,000 in the previous week.
    • The weekly influenza-like illnesses (ILI) general practice (GP) consultation rate decreased to 17 per 100,000 compared with 23.1 per 100,000 in the previous week.
    • Up to the end of week 3 (week ending 19 January 2025), vaccine uptake was 39.5% for those aged under 65 years in a clinical risk group, 34.5% in all pregnant women and 74.4% for all those aged 65 years and over. Uptake was 41.2% for children aged 2 years of age and 43% for children aged 3 years of age.
    • Some indicators suggested an increase in flu activity in children over the last week, this is in line with an expected increase in respiratory virus activity in children following the post Christmas return to school.

    COVID-19 surveillance data for week 3

    • COVID-19 activity remained stable across most indicators and was at baseline activity levels.
    • COVID-19 positivity in hospital settings increased slightly with a weekly mean positivity rate of 2.4%, compared to 2.2% in the previous week. 
    • COVID-19 hospitalisations remained stable at 1.32 per 100,000 compared to 1.35 per 100,000 in the previous week.
    • COVID-19 ICU admissions remained stable at 0.04 per 100,000 compared with 0.04 per 100,000 in the previous week.
    • There were 10 COVID-19 acute respiratory incidents reported in week 3.
    • The highest hospital admission rate was in the North-East, which remained stable at 2.74 per 100,000, compared with 2.78 per 100,000 in the previous week.
    • Those aged 85 years and over had the highest hospital admission rate, which decreased slightly to 14.65 per 100,000 compared with 15.45 per 100,000 in the previous week.  
    • Up to the end of week 3 (week ending 19 January 2025), 23.6% of those under 65 years in a clinical risk group and 59.3% of all people aged over 65 years old, who are living and resident in England had been vaccinated.

    Respiratory syncytial virus (RSV) surveillance data for week 3

    • Respiratory syncytial virus (RSV) activity decreased across most indicators and was circulating at low levels overall.
    • Emergency department attendances for acute bronchiolitis increased.
    • RSV positivity decreased slightly to 4.2% compared with 4.7% in the previous week.
    • Overall, hospital admissions decreased to 1.21 per 100,000 compared with 1.57 per 100,000 in the previous week.
    • UKHSA monitors Human metapneumovirus (hMPV) detections in patients seen in GP practices or tested by hospital laboratories and reports on this in the weekly surveillance report. Most people have had hMPV by the time they are 5 years old and catch it again throughout their lives. In week 3, Human metapneumovirus (hMPV) laboratory test positivity increased to 4.9% from 3.5% in the previous week.

    Dr Jamie Lopez Bernal, Consultant Epidemiologist at UKHSA, said: 

    It’s encouraging that flu activity is continuing to decrease this week and is currently circulating at medium levels. Flu positivity has decreased by 3.6% this week, but we should remember that flu season is not over yet and people should continue to take protective measures to keep us on this downward trend.

    We’re monitoring a slight increase in Influenza B positivity this week, which is to be expected towards the end of winter and the vaccine protects against multiple flu strains, including B. The predominant circulating flu strain continues to be A H1N1 clade 5a.2a. Analysis by UKHSA laboratory scientists shows that the H1N1 component of the flu vaccine is well matched.

    If you’re eligible and have not yet had your flu vaccine, it’s important that you take this offer up if available through local services. This includes anyone recently pregnant or newly diagnosed as in an eligible clinical risk group.

    If you have symptoms of flu or COVID-19 such as a high temperature, cough and feeling tired and achy, try to limit your contact with others, especially those who are vulnerable. If you have symptoms and need to leave the house, our advice remains that you should consider wearing a face covering. Washing hands regularly and using and disposing tissues in bins can reduce the spread of respiratory illnesses.

    Norovirus surveillance data for week 2

    • Norovirus reports in the 2-week period between 30 December 2024 to 12 January 2025 were 12% higher than the previous 2-week period. The total number of reports was 89.8% higher than the 5-season average for the same 2-week period.
    • Rotavirus reporting has started to increase again in recent weeks but was within expected levels during the 2-week period of weeks 1 and 2 of 2025.
    • The number of norovirus outbreaks reported to the Hospital Norovirus Outbreak Reporting System (HNORS) since the start of the 2024/2025 season is 7.2% higher than the 5-season average.
    • During weeks 1 and 2 of 2025, reporting remained highest in adults aged 65 years and over.
    • While some of the increased reporting may be attributable to the increased use of PCR multiplex technology (capable of detecting multiple gastrointestinal pathogens in one test), it is likely that the emergence of an unusual norovirus genotype, GII.17, as well as changes in the epidemiology following the COVID-19 pandemic and other factors are contributing to the observed rise.
    • During the 2024/2025 season to date, the majority (90.5%) of samples characterised were norovirus genogroup 2 (GII), of which the most frequently identified genotype was GII.17 (58%), an increase of this genotype has also been observed in other counties during 2024 and is being closely monitored — at present there is no indication it leads to more severe illness (note: it isn’t accurate to refer to GII.17 as ‘Kawasaki’ and this term is causing confusion with Kawasaki Disease, which is an unrelated disease).
    • Laboratory reports represent just a small proportion of total norovirus cases and it has been estimated that for every case of norovirus reported to national surveillance in the UK there are about 288 in the community that go unreported, representing an annual burden of around 3 million cases.
    • Norovirus symptoms include nausea, vomiting and diarrhoea but can also include a high temperature, abdominal pain and aching limbs. Norovirus infections can cause dehydration, especially in vulnerable groups such as young children and older or immunocompromised people, so if you do get ill it is important to drink plenty of fluids during that time.

    Amy Douglas, Epidemiologist at UKHSA said:

    Norovirus activity has remained high in recent weeks and has started to increase again, as we expected following the post-Christmas return to school and work.

    If you have diarrhoea and vomiting, you can take steps to avoid passing the infection on. Do not return to work, school or nursery until 48 hours after your symptoms have stopped and do not prepare food for others in that time either. If you are unwell, avoid visiting people in hospitals and care homes to prevent passing on the infection in these settings. Washing your hands with soap and warm water and using bleach-based products to clean surfaces will also help stop infections from spreading. Alcohol gels do not kill norovirus so do not rely on these alone.

    Previous

    Thursday 16 January 2025

    This bulletin (formally Weekly Winter Briefing) brings together the latest surveillance data, along with the latest public health advice for flu, COVID-19, RSV and other viruses common in winter.

    In week 2:

    • influenza (flu) activity showed a mixed picture with some recent decline, and was circulating at medium levels
    • COVID-19 activity remained stable across most indicators and was at baseline activity levels
    • Respiratory syncytial virus (RSV) activity decreased across most indicators and was circulating at low levels of activity

    For more information, see the flu, COVID-19 and RSV surveillance report and norovirus surveillance report.

    Flu surveillance data for week 2

    • Flu activity showed a mixed picture with some indicators suggesting that activity may have reached a peak, and declined in recent weeks to medium levels
    • Flu positivity decreased with a weekly mean positivity rate of 20.9%, compared to 28.4% in the previous week (this is based on a percentage of people who test positive among those with symptoms tested)
    • Overall, flu hospitalisations decreased to medium levels of 9.47 per 100,000 population, compared with 13.43 per 100,000 in the previous week.
    • The weekly influenza-like illnesses (ILI) General Practice (GP) consultation rate increased to 23.1 per 100,000 compared with 20.6 per 100,000 in the previous week. Note that this is not considered to indicate rising activity as it follows two weeks with bank holidays, in which the number of GP appointments available was reduced
    • Up to the end of week 2 (week ending 12 January 2025), vaccine uptake stood at 39.1% of those under 65 years in a clinical risk group, 34.2% in all pregnant women and 74.1% in all those aged 65 years and over, 41.1% of children aged 2 years of age and 42.7% of children aged 3 years of age have been vaccinated

    COVID-19 surveillance data for week 2

    • COVID-19 activity remained stable across most indicators and was circulating at baseline levels
    • COVID-19 positivity in hospital settings decreased slightly with a weekly mean positivity rate of 2.1%, compared to 2.3% in the previous week
    • COVID-19 hospitalisations remained stable at 1.34 per 100,000 compared to 1.39 per 100,000 in the previous week
    • COVID-19 ICU admissions remained stable at 0.04 per 100,000 compared with 0.06 per 100,000 in the previous week
    • There were 8 COVID-19 acute respiratory incidents reported in week 2
    • The highest hospital admission rate was in the North-East, which remained stable at 2.74 per 100,000, compared with 2.78 per 100,000 in the previous week
    • Those aged 85 years and over had the highest hospital admission rate, which remained stable at  15.47 per 100,000 compared with 15.13 per 100,000 in the previous week  
    • Up to the end of week 2 (week ending 12 January 2025), 23.6% of those under 65 years in a clinical risk group and 59.2% of all people aged over 65 years old, who are living and resident in England had been vaccinated

    Respiratory Syncytial Virus (RSV) surveillance data for week 2

    • Respiratory syncytial virus (RSV) activity decreased across most indicators and was circulating at low levels overall
    • Emergency department attendances for acute bronchiolitis decreased
    • RSV positivity decreased to 4.7% compared with 6.2% in the previous week
    • Overall, hospital admissions decreased to 1.52 per 100,000 compared with 2.10 per 100,000 in the previous week

    • UKHSA monitors Human metapneumovirus (hMPV) detections in patients seen in GP practices or tested by hospital laboratories and reports on this in the weekly surveillance report. Most people have had hMPV by the time they are five years old and catch it again throughout their lives. In week 2, Human metapneumovirus (hMPV) laboratory test positivity decreased to 3.5% from 4.6% in the previous week

    Dr Conall Watson, Consultant Epidemiologist at UKHSA, said: 

    Flu activity is currently heading in the right direction, falling from high to medium levels overall this week. One of our key indicators is the percentage of positive flu tests, and this has come down from 28% to 21%. This is promising but we are nowhere near out of flu season yet. Mixing increases in January as people return to workplaces and schools which increases the chances for flu viruses to spread. 

    We urge everyone to do their bit to keep us on this downward trend.  If you have symptoms of flu or COVID-19 such as a high temperature, cough and feeling tired and achy, try to limit your contact with others, especially those who are vulnerable. If you have symptoms and need to leave the house, our advice remains that you should consider wearing a face covering. Washing hands regularly and using and disposing tissues in bins can reduce the spread of respiratory illnesses.

    If you’re eligible and haven’t yet had your flu vaccine, it’s important that you take this offer up if available through local services. This includes anyone recently pregnant or newly diagnosed as in an eligible clinical risk group.

    The vaccine protects against multiple flu strains and we are monitoring influenza type B activity closely as this can rise towards the end of winter. The predominant circulating flu strain continues to be A H1N1 clade 5a.2a. Analysis by UKHSA laboratory scientists shows that the H1N1 component of the flu vaccine is well matched.

    Norovirus surveillance data for week 1

    • Norovirus reports in the 2-week period between 23 December to 05 January 2024 were 6.7% lower than the previous 2-week period, although have increased in week 1 of 2025.
    • The decrease over the festive period has also been seen in previous years should be interpreted with caution as likely reflects changes in patterns of healthcare use, social mixing and lagged reporting due to the Christmas holidays, as well as the impact of school holidays. However, the total number of reports was 70.1% higher than the 5-season average for the same 2-week period.
    • Rotavirus reporting has decreased in recent weeks and was within expected levels during the 2-week period of weeks 52 of 2024 and 1 of 2025.
    • The number of norovirus outbreaks reported to the Hospital Norovirus Outbreak Reporting System (HNORS) since the start of the 2024/2025 season is 8.7% higher than the 5-season average.
    • Norovirus reporting remained high across all regions of England and all age groups, with the highest number of reports in adults aged 65 years and over.
    • While some of the increased reporting may be attributable to the increased use of PCR multiplex technology (capable of detecting multiple gastrointestinal pathogens in one test), it is likely that the emergence of an unusual norovirus genotype, GII.17, as well as changes in the epidemiology following the COVID-19 pandemic and other factors are contributing to the observed rise.
    • During the 2024/2025 season to date, the majority (90.4%) of samples characterised were norovirus genogroup 2 (GII), of which the most frequently identified genotype was GII.17 (58.1%), an increase of this genotype has also been observed in other counties during 2024 and is being closely monitored — at present there is no indication it leads to more severe illness (note: it isn’t accurate to refer to GII.17 as ‘Kawasaki’ and this term is causing confusion with Kawasaki Disease, which is an unrelated disease)
    • Laboratory reports represent just a small proportion of total norovirus cases and it has been estimated that for every case of norovirus reported to national surveillance in the UK there are about 288 in the community that go unreported, representing an annual burden of around 3 million cases.
    • Norovirus symptoms include nausea, vomiting and diarrhoea but can also include a high temperature, abdominal pain and aching limbs. Norovirus infections can cause dehydration, especially in vulnerable groups such as young children and older or immunocompromised people, so if you do get ill it is important to drink plenty of fluids during that time.

    Amy Douglas, Epidemiologist at UKHSA said:

    Norovirus activity remains high.

    If you have diarrhoea and vomiting, you can take steps to avoid passing the infection on. Do not return to work, school or nursery until 48 hours after your symptoms have stopped and don’t prepare food for others in that time either. If you are unwell, avoid visiting people in hospitals and care homes to prevent passing on the infection in these settings.  > Washing your hands with soap and warm water and using bleach-based products to clean surfaces will also help stop infections from spreading. Alcohol gels do not kill norovirus so don’t rely on these alone.

    Previous

    Thursday 09 January 2025

    This bulletin (formally Weekly Winter Briefing) brings together the latest surveillance data, along with the latest public health advice for flu, COVID-19, RSV and other viruses common in winter.

    In week 1:

    • COVID-19 activity remained stable across most indicators and was at baseline activity levels
    • influenza (flu) activity showed a mixed picture with some indicators suggesting that activity may have reached a peak, though activity remains at high levels
    • Respiratory syncytial virus (RSV) activity decreased across most indicators and was circulating at low levels

    For more information, see the flu, COVID-19 and RSV surveillance report and norovirus surveillance report.

    Flu surveillance data for week 1

    • Flu activity showed a mixed picture with some indicators suggesting that activity may have reached a peak, though activity remains at high levels
    • flu positivity decreased slightly with a weekly mean positivity rate of 28.1%, compared to 29.7% in the previous week. This is based on a percentage of people who test positive among those with symptoms tested at sentinel “spotter” laboratories, reported through the Respiratory DataMart surveillance system
    • overall, flu hospitalisations remained stable at 13.41 per 100,000, compared with 13.90 per 100,000 in the previous week
    • the weekly influenza-like illnesses (ILI) General Practice (GP) consultation rate increased to 20.6 per 100,000 compared with 13.9 per 100,000 in the previous week
    • up to the end of week 1, vaccine uptake stood at 38.6% of those under 65 years in a clinical risk group, 33.8% in all pregnant women and 73.8% in all those aged 65 years and over. 40.9% of children aged 2 years of age and 42.5% of children aged 3 years of age have been vaccinated

    COVID-19 surveillance data for week 1

    • COVID-19 activity remained stable across most indicators and was circulating at baseline levels
    • COVID-19 positivity in hospital settings decreased with a weekly mean positivity rate of 2.2%, compared to 2.5% in the previous week
    • COVID-19 hospitalisations remained stable at 1.39 per 100,000 compared to 1.32 per 100,000 in the previous week
    • COVID-19 ICU admissions remained stable at 0.06 per 100,000 compared with 0.04 per 100,000 in the previous week
    • there were 12 COVID-19 acute respiratory incidents reported in week 1
    • the highest hospital admission rate was in the North-East at 2.78 per 100,000, increasing from 1.68 per 100,000 in the previous week
    • those aged 85 years and over had the highest hospital admission rate, which increased to 15.36 per 100,000 compared with 12.64 per 100,000 in the previous week
    • up to the end of week 1, 23.5% of those under 65 years in a clinical risk group and 59.1% of all people aged over 65 years old, who are living and resident in England had been vaccinated

    Respiratory syncytial virus (RSV) surveillance data for week 1

    • Respiratory syncytial virus (RSV) activity decreased across most indicators and was circulating at low levels overall
    • emergency department attendances for acute bronchiolitis decreased
    • RSV positivity decreased slightly to 6.2% compared with 7.2% in the previous week
    • overall, hospital admissions decreased to 2.14 per 100,000 compared with 2.48 per 100,000 in the previous week

    Dr Conall Watson, Consultant Epidemiologist at UKHSA, said: 

    We are continuing to see high levels of flu this week and ongoing admissions to hospitals and intensive care.  Although activity has remained stable coming into the new year, influenza activity can be unpredictable as people return to work and school and opportunities for the virus to spread can increase. 

    The predominant circulating flu strain continues to be A H1N1 clade 5a.2a, and the World Health Organization has so far concluded that the H1 component of the flu vaccine is well matched. If you’re still offered a vaccine through local services, it’s important that you take this up, including if you are pregnant or a health and social care worker.

    If you have symptoms of flu or COVID-19 such as a high temperature, cough and feeling tired and achy, try to limit your contact with others, especially those who are vulnerable. If you have symptoms and need to leave the house, our advice remains that you should consider wearing a face covering. Washing hands regularly and using and disposing tissues in bins can reduce the spread of respiratory illnesses.

    Norovirus surveillance data for week 52

    • Norovirus activity has decreased in recent weeks, with reports in the 2-week period between 16 to 29 December 2024 12.1% lower than the previous 2-week period. The decrease over the festive period has also been seen in previous years and should be interpreted with caution as it likely reflects changes in patterns of healthcare use, social mixing and lagged reporting due to the Christmas holidays, as well as the impact of school holidays. However, the total number of reports was 63.6% higher than the 5-season average for the same 2-week period.
    • Rotavirus reporting has decreased in recent weeks and was within expected levels during the 2-week period of weeks 51 and 52.
    • The number of norovirus outbreaks reported to the Hospital Norovirus Outbreak Reporting System (HNORS) since the start of the 2024/2025 season is 11.7% higher than the 5-season average.
    • Norovirus reporting remained high across all regions of England and all age groups, with the highest number of reports in adults aged 65 years and over.
    • While some of the increased reporting may be attributable to the increased use of PCR multiplex technology (capable of detecting multiple gastrointestinal pathogens in one test), it is likely that the emergence of an unusual norovirus genotype, GII.17, as well as changes in the epidemiology following the COVID-19 pandemic and other factors are contributing to the observed high levels.
    • During the 2024/2025 season to date, the majority (89.5%) of samples characterised were norovirus genogroup 2 (GII), of which the most frequently identified genotype was GII.17 (59.7%), an increase of this genotype has also been observed in other counties during 2024 and is being closely monitored — at present there is no indication it leads to more severe illness (note: it isn’t accurate to refer to GII.17 as ‘Kawasaki’ and this term is causing confusion with Kawasaki Disease, which is an unrelated disease)
    • Laboratory reports represent just a small proportion of total norovirus cases and it has been estimated that for every case of norovirus reported to national surveillance in the UK there are about 288 in the community that go unreported, representing an annual burden of around 3 million cases.
    • Norovirus symptoms include nausea, vomiting and diarrhoea but can also include a high temperature, abdominal pain and aching limbs. Norovirus infections can cause dehydration, especially in vulnerable groups such as young children and older or immunocompromised people, so if you do get ill it is important to drink plenty of fluids during that time.

    Amy Douglas, Epidemiologist at UKHSA, said:

    Although there was a decrease in reports of norovirus over the festive period, cases still remain high and we expect levels to rise further with the return to school.

    If you have diarrhoea and vomiting, you can take steps to avoid passing the infection on. Do not return to work, school or nursery until 48 hours after your symptoms have stopped and don’t prepare food for others in that time either. If you are unwell, avoid visiting people in hospitals and care homes to prevent passing on the infection in these settings.

    Washing your hands with soap and warm water and using bleach-based products to clean surfaces will also help stop infections from spreading. Alcohol gels do not kill norovirus so don’t rely on these alone.

    Updates to this page

    Published 6 February 2025

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: Improving miscarriage care

    Source: Scottish Government

    £1.5 million to support delivery of compassionate, high-quality care.

    Women can expect improved miscarriage care Public Health and Women’s Health Minister Jenni Minto has pledged, after unveiling a new framework, backed by £1.5 million funding.

    The framework sets out a range of actions for Scotland’s NHS boards to implement, including ensuring that women going through miscarriage have a separate, private space. It will introduce a graded model of miscarriage care across the country. This means all women can receive tailored support and services, and won’t have to wait until a third miscarriage. This will include access to progesterone prescriptions – where clinically appropriate – both for threatened and recurrent miscarriage.

    These changes will be supported by £1.5 million Scottish Government funding and aim to ensure that early pregnancy care is equitable so that no women are disadvantaged, regardless of where they access and receive care.

    The Minister for Public Health and Women’s Health said:

    “The loss of a baby, no matter at what stage of pregnancy, has a profound and lasting impact on women and their families. To all who have experienced such a tragedy, I offer my deepest sympathy. The Scottish Government recognises this impact and is clear that women and families who have experienced pregnancy or baby loss must be provided with the right information, care and support, tailored to their individual circumstances.

    “I am very grateful to everyone in Scotland’s NHS who works to provide miscarriage care and support.

    “I know there is already a lot of good work underway within NHS Boards to improve miscarriage care services. The 2025-26 Budget, if approved by Parliament, will provide £1.5 million to support NHS Boards to improve delivery of sensitive and compassionate miscarriage care.”

    Kath Abrahams, Chief Executive of pregnancy charity Tommy’s commented:

    “We are delighted to see the Delivery Framework for Miscarriage Care in Scotland launching today. The Framework is a real milestone on the path to excellent care for women and families in Scotland and Tommy’s has been pleased to work closely with our colleagues in Scottish Government as they have developed the Framework, which aims to ensure the right support and care for parents after every tragic loss. With compassionate care at its heart, we are looking forward to continuing to support our Scottish colleagues as they oversee the rollout.”

    The Miscarriage Association’s Chief Executive Vicki Robinson said:

    “We are extremely pleased to see the publication of this important Framework for Miscarriage Care in Scotland, which represents a significant step forward in ensuring that those experiencing miscarriage receive the compassionate, high-quality care they deserve during such a heart-breaking time.

    “This framework is a vital step in providing evidence-based care and offering women additional support in early pregnancy. We are proud to have contributed to its development and look forward to seeing it bring positive change. This is a crucial milestone in ensuring that miscarriage care is accessible, equitable, and compassionate across Scotland.”

    Background

    The Delivery Framework for Miscarriage Care in Scotland, and Progesterone Pathway, will help and support NHS Boards to implement the Programme for Government commitments and support improvements in delivery of miscarriage care.

    Progesterone is a hormone that plays an important role in the menstrual cycle and in maintaining a pregnancy in the early stages. If a woman has miscarried before and is bleeding in early pregnancy, they may benefit from taking progesterone. It may also be suitable for women who have had four or more miscarriages with no bleeding.

    Always get medical help if:

    • you’re bleeding from your vagina
    • you’ve got strong, cramping pain
    • your waters break
    • your baby’s movements have changed, or you haven’t felt them move for a while.

    If you’re registered, contact your midwife or local maternity unit. If you’re not registered, contact your GP or the NHS 24 111 service. Find out more Miscarriage | NHS inform

     Additional quotes:

    Held In Our Hearts Chief Executive Nicola Welsh said:

    “We are very pleased to have been part of the Delivery Framework for Miscarriage Care ensuring the lived experience voices were represented in the key actions of the Framework. Over the last few years, much progress has been made to better understand the impact a miscarriage has on families, and we have come a long way in listening to women’s needs and being able to deliver timely and trauma informed care. Held In Our Hearts offer Hospital to Home care which provides six home visits to those who experience loss from 12 weeks of pregnancy and offer support to anyone who has experienced a miscarriage. Working collaboratively, we must make sure no one is alone in their grief and people have the support they need at a difficult time.  We hope the new Delivery Framework for Miscarriage Care ensures families across Scotland receive the care they need, and deserve, following loss.”

    Sands Chief Executive Dr Clea Harmer said:

    “We welcome the announcement of a Delivery Framework for Miscarriage Care and Progesterone Pathway in Scotland, to ensure that everyone affected by pregnancy loss before 24 weeks gets the high-quality care and support, they need. 

    “The loss of a baby, no matter what stage of pregnancy, is a traumatic event that can have a profound impact on parents and families. Sands will continue to work with the Scottish Government, and all NHS Boards in Scotland, to improve the quality and consistency of care for everyone affected by pregnancy loss.”

    MIL OSI United Kingdom

  • MIL-OSI: Equasens: 2024 annual revenue

    Source: GlobeNewswire (MIL-OSI)

    Villers-lès-Nancy, 6 February 2025 – 6:00 p.m. (CET)

    PRESS RELEASE

    2024 annual revenue: €216.8 million including €58.6 million in Q4 (+2.6% on a reported basis and -0.4% like-for-like)

    Revenue (€&) 2023
    Reported basis
    2024
    Reported basis
    Change /
    Reported basis
    Of which external growth Of which Ségur1 2024

    Of which Ségur 2023

    Like-for-like change
    (organic growth)
    Q1 56.2 53.3 -2.9 -5.2% 2.0 0.3 -1.4 -3.8 -6.7%
    Q2 56.4 54.7 -1.7 -3.0% 1.7 0.3 -1.2 -2.6 -4.6%
    Q3 50.1 50.2 0.1 0.3% 1.8 0.2 -0.3 -1.5 -3.0%
    Q4 57.0 58.6 1.5 2.6% 1.7 0.2 -0.3 -0.2 -0.4%
    Total 219.7 216.8(*) -3.0 -1.4% 7.2 1.1 -3.2 -8.2 -3.7%

    (*)unaudited

    Note: Acquisitions in 2023 and 2024 (Atoopharm, Speach2Sense, Pratilog, ADV in Germany – now Pharmagest Germany) and Digipharmacie) have been restated in the scope of consolidation.
    Maintaining a strategy of external growth, in December 2024 Equasens Group acquired 90% of the capital of Calimed SAS, a software publisher for private practitioners and surgeons (with no consolidated revenue in Q4 2024).

    Equasens Group, (Euronext Paris™ – Compartment B – FR 0012882389 -EQS), a leading provider of digital solutions for healthcare professionals, reported full-year revenue for the 12-month period ending 31 December 2024 of €216.8m, contracting 1.4% on a reported basis. Like-for-like (organic growth), i.e. excluding the effects of acquisitions and the impact of the Ségur digital healthcare investment programme, revenue decreased by 3.7%.

    Annual revenue at 12/31/24 / Division (€m) 2023
    Reported basis
    2024
    Reported basis
    Change /
    Reported basis
    Of which external growth Of which Ségur 2024

    Of which Ségur 2023

    Like-for-like change
    (organic growth)
    Pharmagest 162.7 163.5 0.8 0.5% 7.1 0.5 -1.5 -5.3 -3.3%
    Axigate Link 31.1 32.1 1.0 3.2%   0.3  -1.0 1.7 5.5%
    e-Connect 15.0 11.2 -3.8 -25.3%       -3.8 -25.3%
    Medical Solutions 8.9 7.9 -1.0 -10.9% 0.1 0.3 -0.7 -0.7 -8.1%
    Fintech 2.0 2.0 0.0 -2.1%       0.0 -2.1%
    Total 219.7 216.8 -3.0 -1.4% 7.2 1.1 -3.2 -8.2 -3.7%

    No businesses were transferred between Divisions in FY 2024.

    FY revenue for the 12 month period ending 31 December 2024 / Activities (€m) 2023
    Reported basis
    2024
    Reported basis
    Change / Reported basis
    Sale of configurations and hardware 93.5 86.1 -7.4 -7.9%
    Scalable maintenance and professional training services 78.1 81.0 2.8 3.6%
    Software solutions and subscriptions 45.4 46.8 1.4 3.0%
    Other services (including intermediation) 2.7 2.9 0.2 7.9%
    Total 219.7 216.8 -3.0 -1.4%

    In Q4 2024 alone, Equasens Group registered sales of €58.6m, up 2.6% on a reported basis at 31 December 2023 (-0.4% like-for-like).

    Q4 2024 revenue / Division (€m) 2023
    Reported basis
    2024
    Reported basis
    Change /
    Reported basis
    Of which external growth Of which Ségur 2024

    Of which Ségur 2023

    Like-for-like change
    (organic growth)
    Pharmagest 42.2 43.4 1.2 2.9% 1.7 0.1 -0.2 -0.5 -1.1%
    Axigate Link 8.9 9.5 0.7 7.6%   0.1 -0.1 0.7 7.7%
    e-Connect 3.3 2.9 -0.3 -10.1%       -0.3 -10.1%
    Medical Solutions 2.2 2.2 0.0 -0.9%   0.1 -0.1 0.0 -2.1%
    Fintech 0.6 0.5 -0.1 -11.6%       -0.1 -11.6%
    Total 57.1 58.6 1.5 2.6% 1.7 0.3 -0.4 -0.2 -0.4%
    Q4 2024 revenue highlights by type of business 2023
    Reported basis
    2024
    Reported basis
    Change / Reported basis
    Sale of configurations and hardware 23.2 23.5 0.1 0.4%
    Scalable maintenance and professional training services 19.8 20.4 0.6 3.1%
    Software solutions and subscriptions 13.2 13.8 0.5 4.1%
    Other services (including intermediation) 0.8 1.0 0.2 27.5%
    Total 57.1 58.6 1.5 2.6%
    • In a year marked by political instability, particularly in France, configuration and equipment sales were again heavily impacted on a full-year basis (-7.9%). The recovery initially anticipated in Q3 got off to a slower than expected start with marginal growth in Q4 (+0.4%).
    • Scalable maintenance services and business training continued to display positive momentum with stable growth (+3.1 % in Q4 2024 and +3.6% for the full year).
    • Software solutions and subscriptions performed particularly well in H2 after declining in the first half (reflecting the base effect from Ségur) to achieve 3% growth for the full year.
    • The PHARMAGEST Division recorded annual sales of €163.5m (+0.5%) for the year ended 31 December 2024 on a reported basis, including €7.1m of restated sales arising from acquisitions in 2023 and 2024. On a like-for-like basis, sales for the division declined 3.3% for the full year.

    In Q4 2024, the Division grew 2.9% to €43.4m on a reported basis compared with Q4 2023, including €1.7m in restated sales linked to acquisitions in Q4 2023 and 2024. Like-for-like, the division’s sales declined 1.1% in the last quarter.

    • The Division’s strategy of innovation and bringing new software, hardware and services to market has strengthened its value proposition in terms of pharmacy productivity and automation solutions starting in the third quarter, with, for example, the id.Express payment terminal deployed in France, Germany and Belgium, the new id.Genius module integrating AI into dispensing, and id.Assistance, a new service facilitating the use and adoption of the id. offering on a day-to-day basis.
    • Based on these advances, the Pharmacy business now has a differentiating offering capable of generating revenue from its customer base (€2m at 31/12/2024) and contributing to growth in market share with more than 500 new customers in France and Italy (+€3.5m at 31/12/2024).
    • Digipharmacie, a provider of digital accounts payable management solutions for pharmacies, recently approved as a partner of the French e-reporting platform (Plateforme de Dématérialisation Partenaire or PDP), recorded annual growth of 27%.
    • The shift of the Division to SaaS offering culminated in the launch in September 2024 of the ASCA Dynamics solution, a cloud based version of the electronic label management software developed by Equasens Group. Nearly 250 of the 500 pharmacies added to ASCA’s customer base in 2024 are already equipped with this solution.

    This Division accounts for 75.4% of total revenue.

    • The AXIGATE LINK division registered €32.1m in revenue for the 12 month period ended 31 December 2024 (+3.2% on a reported basis and +5.5% like-for-like). In Q4 2024, the Division grew 7.6% to €9.5m on a reported basis compared with the same period in 2023. Like-for-like, the division’s revenue grew 7.7% in the last quarter.
      • The nursing home sector, which accounts for 53% of the Division’s revenues, experienced a strong growth in 2024, with the addition of 104 new establishments (excluding the UK), bringing its installed base to a total of 3,400 sites. The Titanlink SaaS offering was a resounding success, more than 600 sites equipped out of a total of 2,500 in France and 90 in Belgium out of a total of 932.
      • The Homecare sector also delivered a very solid performance, with a net gain of 20 customers, including 5 Hospital-at-Home programmes. In addition, the sector started rolling out the first version of a software package for regional elderly and disabled homecare centres (Centres de Ressources Territoriales or CRTs) to coordinate patient care. This activity accounts for 22% of the Division’s revenue.
      • The Hospital sector, 12% of the Division’s revenue, grew 4.1% in 2024 compared with 2023 with a net increase of 7 facilities, including 3 major psychiatric establishments. A portion of these orders signed in 2024 will be implemented and recognised in revenue for 2025.
      • The PandaLab Pro secure messaging system recently passed the milestone of 50,000 independent users or private organisations and 360,000 messages sent per month. 2024 experienced a growth in the number of use cases, particularly in teleconsultation, remote assistance and outpatient prescriptions, with the latter reaching 85,000 prescriptions exchanged in December 2024 alone.

    This Division accounts for 14.8% of total revenue.

    • The E-CONNECT division had revenue of €11.2m for the year ended 31 December 2024 (down 25.3% on a reported basis). Revenue in Q4 2024 was down 10.1% in relation to the same quarter in 2024 to €2.9m, representing a decline significantly less than in previous quarters.
      • Despite challenging market conditions, 2024 remained a year of investment, following an exceptional period in 2023 which benefited from a one-off regulatory development (the discontinuation of Application Reader Terminal sales).
      • In Q4 2024, Kapelse’s eS-KAP+ mobility solution was authorised for all prescribing healthcare professionals, midwives and health centres. This latest certification completes the “auxiliary health practitioners” approval obtained in 2024 and extends the number of partner software publishers who are starting to integrate eS-KAP+ into their business applications.
      • Sales of KAP-eCV (the electronic French health insurance card reader) got off to a promising start, with several thousand readers sold in Q4.
      • In November 2024, the new NOVIAcare offering (entailing a switch to modular sales) met with considerable success when it was unveiled at the Silver Economy Expo international exhibition in Cannes, confirming the potential of the first scalable and modular telecare solution on the market.

            This Division accounts for 5.2% of total revenue.

    • The MEDICAL SOLUTIONS Division recorded revenue of €2.2m in Q4 2024, down slightly (-0.9%) on Q4 2023. Reflecting the diminishing impact of the base effect from the Segur digital healthcare investment programme, the decline for the full year was limited to -10.9% to €7.9m, compared with -19.1% in H1 2024.
      • The launch of LOQUii, the AI voice consultation assistant, in November 2024, provides further confirmation of the recovery. By adopting a “Try Before You Buy” formula, more than 500 doctors used the solution in Q4, highlighting the potential for significant growth from Q1 2025 onwards, once the initial trial period is over.
      • At the same time, the roll-out of the MS.Safe online backup solution that combines safety and ease of use attracted around 50 users in less than two months.

    The Division accounts for 3.6% of total revenue.

    • The FINTECH Division  recorded revenue of €0.5m (-11.6%) in Q4 2024, and €2.0m for the full year (-2.1% compared with 2023).
      • The new Dispay digital bankcard payment service now integrated into the medical software solution of healthcare professionals resulted in subscriptions by 80 customers in Q4 and the Division remains confident that it will generate additional revenues as its customer base expands.

    The Division accounts for 1.0% of total revenue.

    2025 outlook
    Based on the encouraging indicators for Q4 2024, the Group is looking ahead to 2025 with confidence. Positive momentum is expected for the first half of the year, benefiting notably by a favourable base effect at the start of the year. A significant acceleration is expected in the second half with nominal growth of nearly 10%, driven by the capital expenditures and the roll-out of new solutions (software, hardware and services).

    In this context, Equasens Group is in the process of implementing a major strategic transformation to SaaS (Software as a Service) business model. This transition entails the gradual migration from solutions hosted at healthcare professionals’ premises to solutions hosted in the Group’s data centers which are certified Health Data Hosting (HDS) and ISO 27001. The new add-on modules are now developed almost exclusively for SaaS solutions which will increase the proportion of recurring revenues. This transformation is driven by a robust cloud infrastructure and customised support to assist our customers with their digital transition.

    At the same time, the Group is continuing to invest in Artificial Intelligence and accelerating its integration into its business tools to enhance its range of decision-making tools. This development brings real added value to healthcare professionals by making the prescription process more secure, providing personalised patient support and optimized time management.

    Backed by a solid financial structure, the Group will continue to monitor potential opportunities for external growth.

    This guidance does not take into account the potential effect of cyclical or macro-economic events that could have a direct or indirect impact on the healthcare sector.

    Financial calendar:

    • FY 2024 results: 29 March 2025
    • Presentation of 2024 annual results (SFAF): 31 March 2025, Paris
    • Q1 2025 revenue: 12 May 2025
    • Annual General Meeting: 26 June 2025
    • Q2 2025 revenue: 31 July 2025
    • H1 2025 results: 26 September 2025
    • Presentation of H1 2025 results to analysts (SFAF): 29 September 2025
    • Q3 2025 revenue: 5 November 2025
    • FY 2025 revenue: 5 February 2026

    About Group Equasens

    Founded over 35 years ago, Equasens Group, a leader in digital healthcare solutions, today employs over 1,300 people across Europe.
    Equasens Group’s specialised business applications facilitate the day-to-day work of healthcare professionals and their teams, working in private practice, collaborative medical structures or healthcare establishments. The Group also provides comprehensive support to healthcare professionals in the transformation of their profession by developing electronic equipment, digital solutions and healthcare robotics, as well as data hosting, financing and training adapted to their specific needs.
    And reflecting the spirit of its tagline “Technology for a More Human Experience”, the Group is a leading provider of interoperability solutions that improve coordination between healthcare professionals, their communications and data exchange resulting in better patient care and a more efficient and secure healthcare system.

    Listed on Euronext Paris™ – Compartment B

    Indexes: MSCI GLOBAL SMALL CAP – GAÏA Index 2020 – CAC®SMALL and CAC®All-Tradable
    Included in the Euronext Tech Leaders segment and the European Rising Tech label

    Eligible for the Deferred Settlement Service (“Service à Réglement Différé” – SRD) and equity savings accounts invested in small and mid caps (PEA-PME).
    ISIN: FR 0012882389 – Ticker Code: EQS

    Get all the news about Equasens Group www.equasens.com and on LinkedIn

    CONTACTS

    EQUASENS Group
    Analyst and Investor Relations:
    Chief Administrative and Financial Officer: Frédérique Schmidt
    Tel: +33 (0)3 83 15 90 67 – frederique.schmidt@equasens.com

    Financial communications agency:
    FIN’EXTENSO – Isabelle Aprile

    Tel.: +33 (0)6 17 38 61 78 – i.aprile@finextenso.fr

    Forward-looking statements
    This press release contains forward-looking statements that are not guarantees of future performance and are based on current opinions, forecasts and assumptions, including, but not limited to, assumptions about Equasens’ current and future strategy and the environment in which Equasens operates. These involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements, or industry results or other events, to materially differ from those expressed in or implied by such forward-looking statements. These risks and uncertainties include those detailed in Chapter 3 “Risk factors” of the Universal Registration Document filed with the French financial market authority (Autorité des Marchés Financiers or AMF) on April 29, 2024 under number D.24-0366. These forward-looking statements are valid only as of the date of this press release.


    1 An investment programme rolled out by the French government to support the national strategy for eHealth acceleration.

    Attachment

    The MIL Network

  • MIL-OSI United Nations: Secretary-General’s press encounter on the Democratic Republic of the Congo

    Source: United Nations secretary general

    Good morning. 

    I wanted to say a few words about the deeply concerning situation in the Democratic Republic of the Congo.

    We are at a pivotal moment and it is time to rally together for peace. 

    Tomorrow, leaders from the East African Community and the Southern African Development Community will take part in a Summit in Tanzania. 

    The focus will be addressing the crisis in the face of the offensive by the M23, supported by the Rwandan Defence Forces.

    Next week, in Addis Ababa, I will take part in a Summit-level meeting of the African Union Peace and Security Council where this crisis will be also front and centre.

    In advance of these crucial gatherings, I want to make a special appeal for peace.  

    Thousands of people have been killed – including women and children – and hundreds of thousands have been forced from their homes in the eastern DRC.

    We also see the continued threat by other armed groups, either Congolese or foreign.

    All of this is having an enormous human toll. 

    We have countless reports of human rights abuses, including sexual and gender-based violence, forced recruitment, and the disruption of lifesaving aid.

    The humanitarian situation in and around Goma is perilous.

    Hundreds of thousands of people are on the move, with many of the previous sites hosting displaced people north of the city now looted, destroyed or abandoned. 

    Healthcare facilities are overwhelmed. 

    And other basic services – including schools, water, electricity, phone lines and the internet – are severely limited.

    Meanwhile, the conflict continues to rage in South Kivu and risks engulfing the entire region. 

    I want to pay tribute to all those who have lost their lives, including MONUSCO blue helmets and regional forces. 

    And I express my solidarity with the Congolese people who find themselves yet again the victims of a seemingly endless cycle of violence.

    As the Summit in Tanzania gets underway, and as I prepare to leave for Addis Ababa, my message is clear: 

    Silence the guns. 

    Stop the escalation.

    Respect the sovereignty and territorial integrity of the Democratic Republic of the Congo.

    Uphold international human rights law and international humanitarian law.

    There is no military solution.

    It is time for all the signatories of the Peace, Security and Cooperation Framework for the DRC and the region to honour their commitments.

    It is time for mediation.  It is time to end this crisis.  It is time for peace. 

    The stakes are too high.

    We need the active and constructive role of all players — namely neighbouring countries, subregional organizations, the African Union and the United Nations.

    Let us all act together for peace.

    Thank you.
     

    MIL OSI United Nations News

  • MIL-OSI United Kingdom: Awaab’s Law to force landlords to fix dangerous homes

    Source: United Kingdom – Executive Government & Departments

    From October, social landlords to be forced to investigate and fix dangerous damp and mould in set time periods and repair all emergency hazards within 24 hours

    • From October, social landlords will be forced to investigate and fix dangerous damp and mould in set time periods, as well as repair all emergency hazards within 24 hours
    • Government to introduce vital legislation in honour of two-year-old Awaab Ishak who tragically died following prolonged exposure to damp and mould
    • Major step forward in mission to transform housing safety and quality

    Landmark reforms to force landlords to fix dangerous homes or face the full force of the law will be introduced for the first time later this year.

    As part of the government’s mission to transform the safety and quality of social housing, Awaab’s Law will come into force from October, ensuring social landlords have to investigate and fix dangerous damp and mould within a set amount of time as well as repair all emergency hazards within 24 hours.  Landlords who fail to comply face being taken to court, with social tenants able to use the full powers of the law to hold them to account.

    Awaab’s Law will be introduced through a phased approach to ensure it is applied as effectively as possible. This means that the protections it provides to damp and mould will be introduced quickly, which would not have been possible if the government applied the law to a wider group of hazards from the outset. This will also allow the government to test and learn so that the reforms benefit social tenants and secure the lasting legacy that Awaab Isaak’s family have fought so hard for. 

    The vital reforms will help drive a transformational and lasting change in the safety and quality of social housing, supporting the government’s pledge through the Plan for Change to deliver the biggest boost in social and affordable housing in a generation and build 1.5 million homes.

    The law is a lasting legacy to two-year-old Awaab Ishak, who tragically died after being exposed to mould at his Rochdale home in December 2020. In the wake of this tragedy, Awaab’s family has fought to secure justice, not only for their son but for all those who live in social housing.

    Deputy Prime Minister Angela Rayner said:

    “We have a moral duty to ensure tragedies like the death of Awaab Ishak never happen again.

    “Landlords cannot be allowed to rent out dangerous homes and shamelessly put the lives of their tenants at risk.

    “Our new laws will force them to fix problems quickly, so that people are safe in their homes and can be proud to live in social housing.”

    From October, Awaab’s Law will force landlords to fix damp and mould as well as carry out emergency repairs. We will then take a step-by-step approach to make the law stronger over time so that landlords will be legally required to fix all dangerous hazards from 2027. These repairs will have to be delivered within set timescales to ensure that landlords are meeting their responsibilities.

    However, social landlords must continue to fix dangerous issues in their homes before Awaab’s Law is fully implemented. They already have a duty to keep their homes fit for human habitation and to remedy disrepair, and they must also ensure that their homes meet the Decent Homes Standard. Awaab’s Law will set clearer and stronger laws to ensure that tenants are living in safe homes.

    Housing Minister Matthew Pennycook said:

    “Awaab Ishak’s family have tenaciously and courageously fought to secure justice, not only for their son but for all those who live in social housing.

    “Awaab’s Law will help to drive a transformational and lasting change in the safety and quality of social housing, ensuring tenants are treated with fairness and respect”.

    In the coming months we will bring forward further reforms designed to drive up standards across social housing and to build greater trust and transparency between landlords and tenants. This government will:

    • Introduce powers through the Renters’ Rights Bill to extend Awaab’s Law to the private rented sector. We will consult on how to apply Awaab’s Law to privately rented homes in a way that works for the sector and is fair and proportionate for tenants and landlords.
    • Consult on a new Decent Homes Standard and minimum energy efficiency standards, to ensure tenant’s homes are made safe, warm, and free from disrepair.
    • Legislate to require social landlords to carry out electrical safety checks at least every five years, as well as mandatory appliance inspections on all electrical appliances that are provided by the landlord.

    Notes to editors

    • We are intending to lay the Awaab’s Law regulations in parliament as quickly as we can to secure these protections and provide the sector with clarity and time to prepare ahead of requirements which will come into force in October of this year. 
    • In 2023, 7% of social rented homes had a damp problem and 4% had hazards rated at the most dangerous ‘category 1’ level.
    • Our phased approach will work as follows:

    • From October 2025 social landlords will have to address damp and mould hazards that present a significant risk of harm to tenants to fixed timescales.
    • From October 2025 social landlords will also have to address all emergency repairs including for damp and mould or other hazards as soon as possible and within no longer than 24 hours.
    • In 2026, requirements will expand to apply to a wider range of hazards. In addition to damp and mould, the hazards we expect to extend Awaab’s Law to in this second stage of implementation include excess cold and excess heat; falls; structural collapse; fire, electrical and explosions; and hygiene hazards.
    • Then in 2027, the requirements of Awaab’s Law will expand to the remaining hazards as defined by the HHSRS (excluding overcrowding). The full list of hazards can be found in schedule 1 to the Housing Health and Safety Rating System (England) Regulations 2005.

    Updates to this page

    Published 6 February 2025

    MIL OSI United Kingdom

  • MIL-OSI USA: Louisiana Doctor Sentenced for Illegally Distributing Over 1.8M Doses of Opioids in $5.4M Health Care Fraud Scheme

    Source: US State of North Dakota

    A Louisiana physician was sentenced yesterday to 87 months in prison for conspiring to illegally distribute over 1.8 million doses of Schedule II controlled substances, including oxycodone, hydrocodone, and morphine, and for defrauding health care benefit programs of more than $5.4 million.

    According to court documents and evidence presented at trial, Adrian Dexter Talbot M.D., 59, of Slidell, owned and operated Medex Clinical Consultants (Medex), located in Slidell. Medex was a medical clinic that accepted cash payments from individuals seeking prescriptions for Schedule II controlled substances. Talbot routinely ignored signs that individuals frequenting Medex were drug-seeking or abusing the drugs prescribed. In 2015, Talbot took a full-time job in Pineville, Louisiana, and although he was no longer physically present at the Slidell clinic, he pre-signed prescriptions, including for opioids and other controlled substances, to be distributed to individuals there whom he did not see or examine. In 2016, Talbot hired another practitioner who, at Talbot’s direction, also pre-signed prescriptions to be distributed to individuals in exchange for cash deposited into a Medex bank account. The evidence also demonstrated that Talbot falsified patient records to cover up the scheme and to make it appear as though he was routinely examining the patients. With Talbot’s knowledge, these individuals filled their prescriptions using their insurance benefits, thereby causing health care benefit programs, including Medicare, Medicaid, and Blue Cross Blue Shield of Louisiana, to be fraudulently billed for controlled substances that were prescribed without an appropriate patient examination or determination of medical necessity.

    On July 22, 2024, Talbot was convicted by a jury in the Eastern District of Louisiana of one count of conspiracy to unlawfully distribute and dispense controlled substances, four counts of unlawfully distributing and dispensing controlled substances, one count of maintaining a drug-involved premises, and one count of conspiracy to commit health care fraud.

    Supervisory Official Antoinette T. Bacon of the Justice Department’s Criminal Division, the U.S. Attorney’s Office for the Eastern District of Louisiana, Special Agent in Charge Jason E. Meadows of the Department of Health and Human Services Office of Inspector General (HHS-OIG), Special Agent in Charge Kris Raper of the Department of Veterans Affairs Office of Inspector General (VA-OIG)’s South Central Field Office, Assistant Director Chad Yarbrough of the FBI’s Criminal Investigative Division, Acting Special Agent in Charge Stephen A. Cyrus of the FBI New Orleans Field Office, and Louisiana Attorney General Liz Murrill made the announcement.

    HHS-OIG, VA-OIG, FBI, and the Louisiana Medicaid Fraud Control Unit investigated the case.

    Trial Attorneys Sara E. Porter and Gary A. Crosby II, Assistant Chief Justin Woodard, and Deputy Chief Kate Payerle of the Criminal Division’s Fraud Section prosecuted the case.

    The Fraud Section leads the Criminal Division’s efforts to combat health care fraud through the Health Care Fraud Strike Force Program. Since March 2007, this program, currently comprised of nine strike forces operating in 27 federal districts, has charged more than 5,400 defendants who collectively have billed federal health care programs and private insurers more than $27 billion. In addition, the Centers for Medicare & Medicaid Services, working in conjunction with HHS-OIG, are taking steps to hold providers accountable for their involvement in health care fraud schemes. More information can be found at www.justice.gov/criminal-fraud/health-care-fraud-unit. 

    MIL OSI USA News

  • MIL-OSI Security: Louisiana Doctor Sentenced for Illegally Distributing Over 1.8M Doses of Opioids in $5.4M Health Care Fraud Scheme

    Source: United States Attorneys General

    A Louisiana physician was sentenced yesterday to 87 months in prison for conspiring to illegally distribute over 1.8 million doses of Schedule II controlled substances, including oxycodone, hydrocodone, and morphine, and for defrauding health care benefit programs of more than $5.4 million.

    According to court documents and evidence presented at trial, Adrian Dexter Talbot M.D., 59, of Slidell, owned and operated Medex Clinical Consultants (Medex), located in Slidell. Medex was a medical clinic that accepted cash payments from individuals seeking prescriptions for Schedule II controlled substances. Talbot routinely ignored signs that individuals frequenting Medex were drug-seeking or abusing the drugs prescribed. In 2015, Talbot took a full-time job in Pineville, Louisiana, and although he was no longer physically present at the Slidell clinic, he pre-signed prescriptions, including for opioids and other controlled substances, to be distributed to individuals there whom he did not see or examine. In 2016, Talbot hired another practitioner who, at Talbot’s direction, also pre-signed prescriptions to be distributed to individuals in exchange for cash deposited into a Medex bank account. The evidence also demonstrated that Talbot falsified patient records to cover up the scheme and to make it appear as though he was routinely examining the patients. With Talbot’s knowledge, these individuals filled their prescriptions using their insurance benefits, thereby causing health care benefit programs, including Medicare, Medicaid, and Blue Cross Blue Shield of Louisiana, to be fraudulently billed for controlled substances that were prescribed without an appropriate patient examination or determination of medical necessity.

    On July 22, 2024, Talbot was convicted by a jury in the Eastern District of Louisiana of one count of conspiracy to unlawfully distribute and dispense controlled substances, four counts of unlawfully distributing and dispensing controlled substances, one count of maintaining a drug-involved premises, and one count of conspiracy to commit health care fraud.

    Supervisory Official Antoinette T. Bacon of the Justice Department’s Criminal Division, the U.S. Attorney’s Office for the Eastern District of Louisiana, Special Agent in Charge Jason E. Meadows of the Department of Health and Human Services Office of Inspector General (HHS-OIG), Special Agent in Charge Kris Raper of the Department of Veterans Affairs Office of Inspector General (VA-OIG)’s South Central Field Office, Assistant Director Chad Yarbrough of the FBI’s Criminal Investigative Division, Acting Special Agent in Charge Stephen A. Cyrus of the FBI New Orleans Field Office, and Louisiana Attorney General Liz Murrill made the announcement.

    HHS-OIG, VA-OIG, FBI, and the Louisiana Medicaid Fraud Control Unit investigated the case.

    Trial Attorneys Sara E. Porter and Gary A. Crosby II, Assistant Chief Justin Woodard, and Deputy Chief Kate Payerle of the Criminal Division’s Fraud Section prosecuted the case.

    The Fraud Section leads the Criminal Division’s efforts to combat health care fraud through the Health Care Fraud Strike Force Program. Since March 2007, this program, currently comprised of nine strike forces operating in 27 federal districts, has charged more than 5,400 defendants who collectively have billed federal health care programs and private insurers more than $27 billion. In addition, the Centers for Medicare & Medicaid Services, working in conjunction with HHS-OIG, are taking steps to hold providers accountable for their involvement in health care fraud schemes. More information can be found at www.justice.gov/criminal-fraud/health-care-fraud-unit. 

    MIL Security OSI

  • MIL-OSI: NOTICE TO DISREGARD — Phunware, Inc.

    Source: GlobeNewswire (MIL-OSI)

    AUSTIN, Texas, Feb. 06, 2025 (GLOBE NEWSWIRE) — We are advised by Phunware, Inc. that journalists and other readers should disregard the news release, “Phunware Mobile Hospitality Solution Deployed at JW Marriott Phoenix Desert Ridge Resort & Spa” issued February 5, 2025, over GlobeNewswire.

    The MIL Network

  • MIL-OSI USA: NEWS: Sanders, Murray, Baldwin, Scott, DeLauro Demand Answers on Trump’s Plans to Dismantle Education Department

    US Senate News:

    Source: United States Senator for Vermont – Bernie Sanders

    WASHINGTON, Feb. 6 — Sen. Bernie Sanders (I-Vt.), Ranking Member of the Senate Health, Education, Labor and Pensions (HELP) Committee, alongside Sens. Patty Murray (D-Wash.), Vice Chair of the Senate Appropriations Committee, and Tammy Baldwin (D-Wis.), Ranking Member of the Senate Appropriations Subcommittee on Labor, Health, and Human Services, and Education, and Reps. Bobby Scott (D-Va.), Ranking Member of the House Committee on Education and Workforce, and Rosa DeLauro (D-Conn.), Ranking Member of the House Appropriations Committee, sent a letter warning against the Trump administration’s reported plans to unilaterally dismantle the Department of Education. The lawmakers asked the acting Secretary of Education for answers on recent actions taken by the Trump administration to put federal workers on administrative leave, coerce employees into leaving their jobs, provide access to students’ sensitive data, and illegally freeze vital funding.

    “Over the course of two weeks, the Trump Administration issued sweeping executive orders and sought to broadly and illegally freeze federal financial assistance,” wrote Sanders and the lawmakers. “Federal employees have been targeted, in some cases for simply following the law. Elon Musk is attempting to shut down the work of entire agencies while gaining access to some of the federal government’s most far reaching and sensitive data systems. Media reports indicate a similar effort may be underway at the Department of Education.” 

    “We will not stand by and allow this to happen to the nation’s students, parents, borrowers, educators, and communities. Congress created the Department to ensure all students in America have equal access to a high-quality education and that their civil rights are protected no matter their zip code,” continued the lawmakers. “We urge you to provide information on the steps the Department is taking to ensure the continuity of programs that Americans depend on, the ability of the Department to effectively administer programs for their intended purposes without waste, fraud and abuse, and the safeguards in place to protect student data privacy.” 

    The lawmakers note that Trump and Elon Musk have not shared any plans regarding intended changes to the Department of Education with the Congressional committees responsible for its oversight and funding. In their letter, they request information about access to the Department’s sensitive data and steps taken to safeguard it, communications and details regarding Department employees who have been placed on leave and confirmation that no awards have been blocked or terminated. 

    To read the full letter, click here. 

    MIL OSI USA News

  • MIL-OSI USA: Trump Tariffs, Trade War Concerns Heard During Welch’s Roundtable with Vermont Businesses and Farmers

    US Senate News:

    Source: United States Senator Peter Welch (D-Vermont)

    WASHINGTON, D.C. — Wednesday afternoon, U.S. Senator Peter Welch (D-Vt.), a member of the Senate Finance Committee, convened Vermont businesses for a virtual roundtable to hear about the chaos caused by President Trump’s misguided tariff policies and his Trade War. Earlier this week, the president agreed to pause new 25% tariffs on imports from Canada and Mexico for 30 days, as well as 10% tariffs on imports of oil from Canada—which he had announced days prior, prompting immediate retaliation by Canada and Mexico. President Trump did not pause new 10% tariffs on imports from China. He has also threatened tariffs on imports from the European Union. 
    “These Trump Tariffs are of enormous concern because of their real practical impacts on enterprises, your companies, on your ability to do your work,” said Senator Welch during the event. “The concerns that I’ve seen and expressed to me by Vermonters are concerns that are being expressed to my Republican colleagues…I think that helps put us in a position to push back and be successful. 
    “Every single day, I’m going to be thinking about how this impacts you, and on Vermont, because each of you represent a significant part of the Vermont economy, and you certainly represent the Vermont spirit….I want to do everything I can to allow you to continue being successful doing what you’re doing.” 
    After President Trump’s decision to pause tariffs Canada and Mexico on Monday for 30 days, Senator Welch released the following statement: 

    “President Trump temporarily backtracking on his Trade War does nothing to give Vermont families, businesses, and farms the economic stability they deserve. Tariffs are taxes, and Trump just made it clear he’s fine with raising taxes on American families,” said Sen. Welch. 

    Senator Welch was joined by Vermont business owners, dairy and vegetable farmers, maple sugar makers, manufacturers, craft brewers, home heating and energy importers, home construction manufacturing, retailers, bankers, technology leaders, health care experts, transportation industry experts, local and state leaders, and others impacted by tariffs and the president’s reckless economic policies.  
    During the virtual roundtable, he heard clear concerns from Vermonters, including:    
    “It feels like death by a thousand cuts.” – Stoni Tomson, a small-scale vegetable farmer in Huntington, VT 
    “Adding a tariff will either lead to drug shortages in the short term, or long-term significant price increases.” –  Jason Williams, University of Vermont Health Network 
    “If the 25% tariff was applied in full, it would be about a $130,000 – $150,000 unbudgeted hit to our food procurement efforts. And as a charitable organization, we don’t have a consumer to pass along that cost to.” –  Jason Maring, Vermont Foodbank 
     “The ripple-effects that this could have on energy markets, and of course manufacturing, is very heavy.” – Catherine de Ronde, Agri-Mark 
    “We’re grateful for the pause, and hopeful you can do what you can do to make sure it never comes back.” – Matt Cota, Meadow Hill Consulting 
    “I’m just concerned in general that it’s going to further stagnate the ability for some of these much-needed construction projects to move forward.” – Matt Cook, PC Construction 
    “We would be strongly affected by the tariffs in terms of equipment costs for U.S. producers… I’m very concerned with the possible effects of this.” – Dave Folino, Vermont maple producer 
    “I can foresee this making homes unaffordable—which they already are.” – Denis Bourbeau, Bourbeau Custom Homes 
    “Our industry has grown in production almost 500% over the last 20 years, and these tariffs would go a long way towards potentially slowing that production.” – Alison Hope, Vermont Maple Sugar Makers Association 
    “That kind of jolt to our budget—there’s just not room.” – Peter Kahn, Sienna Construction 
    “There’s just so much unknown, and I’m concerned about the impact on our customers—I’m worried that we’ll lose customers…All of this hurts everyone. It makes everything more expensive.” – Ashley Adams, P.G. Adams 
    “That would basically squeeze us out of the marketplace.” – Melanie Harrison, a small organic dairy farmer in Addison, VT 
    “Even though the tariffs aren’t in effect, we’re definitely already feeling the effects.” – Elise Magnant, small organic vegetable farmer in Plainfield, VT 
    “We’re all working on a very slim margin.” – Steve Parkes, Drop In Brewing 
    Today, Senator Welch will take these stories and the voices of Vermonters to the confirmation hearing for President Trump’s pick for U.S. Trade Representative, Jamieson Greer, who will lead the President’s tariff strategy.  
    On Tuesday, Senator Welch took to the Senate floor to blast the proposed tariffs, which would be a tax on Vermonters. Attendees and constituents are invited to share how President Trump’s economic policies will impact their family, farm, or community by sharing their story on Senator Welch’s website. 
    This event follows a roundtable Senator Welch held in St. Albans on Monday, January 27th, where he heard from businesses and state and local leaders about the President’s threats to reignite a trade war with Canada, Mexico, and China. 
    In many cases, Vermont manufacturers buy imports from Canada to manufacture into products.  However, the ability of Vermont’s small manufacturing businesses to absorb a 25% increase in costs on parts or raw materials is limited. Tariffs on Canada and Mexico could result in layoffs or higher homebuilding costs, increased costs of grain for farmers, and more expensive equipment for maple producers, among other costs that will get passed on to the consumer. 

    MIL OSI USA News

  • MIL-OSI USA: Eagles Autism Foundation Awards Research Funding to UConn School of Medicine

    Source: US State of Connecticut

    Just in time for the Super Bowl, researchers at UConn School of Medicine are part of a big win for autism research.

    UConn School of Medicine’s innovative autism research has been prestigiously awarded by the Eagles Autism Foundation to be one of its 22 cutting-edge autism research projects selected to receive a slice of $8.1 million in grant funding raised by fans.

    The grant funding was all powered by the proceeds raised by participants for the 2024 Eagles Autism Challenge and the Eagles Autism Foundation’s other annual fundraising initiatives. Impressively, since 2018, 169 autism research projects and community grants have been funded by the Foundation nationally and internationally, which is dedicated to raising funds for innovative autism research and care programs to assist those currently affected by autism, as well as future generations to make a lasting impact in the field of autism.

    Dr. Eric S. Levine.

    For the last three years, as a proud Eagles fan (and also a life-long Patriots fan) and professor of Neuroscience at UConn School of Medicine, Dr. Eric S. Levine has served on the Eagles Autism Foundation’s Advisory Board as a research expert reviewing submitted research grant proposals.

    But last year Levine decided to apply for a grant himself for his own cutting-edge UConn neuroscience research lab’s work exploring autism’s genomic genesis, and he won!

    Levine’s new award grants his lab over the next two years $400,000 in research funding to expand its laboratory investigations to identify genetic pathways that may cause autism spectrum disorders and better ways to study them.

    To start, his team has been studying two rare, genetic disease syndromes that also result in profound autism, Angelman Syndrome and Dup15q Syndrome. They impact about 1 in 5,000 children. While it still is not clear yet scientifically about autism spectrum disorders’ genetic origins, it is known that both of these autism-linked syndromes are connected to a child’s genetic differences that lead to a missing piece of a chromosome (Angelman Syndrome) or chromosomal duplication (Dup15q Syndrome) in the same 15q11-q13 region.

    Levine’s cutting-edge autism research at UConn is reprogramming the donated skin or blood cells of Angelman or Dup15q syndrome patients to develop them in the lab into brain cells that exactly mirror each patient’s genomics for further study. These green flashing neuronal cells are being analyzed by Levine’s Lab for their physical structure, intracellular calcium dynamics, and functional electrical activity (Image of Levine Lab).

    In this region, Levine has been studying the impact of the genetic deletions or duplications on the behavior and activity of neuronal brain cells. In contrast to single-gene mouse models, amazingly these studies use skin cells or blood cells obtained from patients living with either Angelman or Dup15q syndrome that are then reprogrammed and grown in the lab at UConn School of Medicine to develop into brain cells that mirror exactly each patient’s genomics.

    “This is really unique, personalized medicine, and a better way for us to study the genomics and physiology of a real child’s brain cells and the possible role multiple genes may be playing leading to autism. All kids are different. We can analyze the physical structure of their neurons, measure intracellular calcium dynamics, and record functional electrical activity,” says Levine, who has received donations of cells from families for study. “It’s very exciting to pivot our autism research to translational research studying actual patient-derived human neurons.”

    (Levine Lab image)

    In his translational research efforts, Levine hopes to compare neurons of patients and identify what role various genes play in the brain cells of the patients with syndromes also causing autism, and how their brain cells behave differently, and even test what possible current drugs or new drugs might be beneficial to patients to improve both their symptoms and quality of life.

    “There is so much to learn about the brain,” says Levine, whose work as a neuroscientist every day is driven by his fierce curiosity to learn more and more about how the brain works, and also inspired by the autism patients and families he has had the privilege to meet through the Eagles Autism Foundation over the last few years.

    “The families I have met are so grateful for our autism research efforts, and more hope is on the way. It is a very exciting time for autism research and real, tangible progress and results with research advances and drug clinical trials,” says Levine.

    “Our focus at UConn is finding the next generation of therapies,” says Levine, whose ultimate goal for his autism research is exploring the future power of gene testing and gene therapy for autism spectrum disorders and related-syndromes, including very early-on in life whether in-utero or during a young child’s life.

    “It’s challenging, but the goal is gene therapy to reduce the expression of any uncovered genetic mutations or find a way to silence these problematic genes in neurons. Finding a way to do so, would have a significant effect on autism spectrum disorder patients,” Levine says.

    (Levine Lab image).

    His research team has already shown there is a driver gene of UBE3A, which breaks down other cellular proteins in neurons, which can be either under- or overexpressed in the Angelman and Dup15q syndromes. But Levine and his team are turning their attention and focus to other genes in that same 15q11-q13 region such as GABA-A receptors and HERC2 that could also be contributing to autism spectrum disorders.

    “If we can better understand the common pathway in the brain for these two genetic syndromes that lead to autism, we may someday understand other forms of autism, especially what causes behavioral issues such as loss of verbal communication, cognitive deficits, and impaired motor-function skills,” says Levine.

    “I love being a part of this awesome Eagles Autism Foundation effort,” says Levine of UConn medical school’s Department of Neuroscience. “They are raising more and more funding for advancing autism research every year, including basic research funding. The better the Eagles team does, the more money that is raised. I am rooting for the Eagles and more winning touchdowns helping to advance our scientific insights into autism.”

    In addition to transformational research project funding like Levine’s, the proceeds are also heartwarmingly supporting community grants to organizations enhancing the lives of those affected by autism.

    “This year’s scientific review process was one of the most competitive evaluations we ever had,” says Jeffrey Lurie, chairman and CEO, Philadelphia Eagles. “The number of submissions we received in such a short period of time speaks to how much the field of autism research and care has evolved. For far too long, autism was misunderstood, underfunded, and under-researched. While there is still more work to be done, we are now seeing autism being prioritized at the highest level by some of the most recognized institutions around the world. We thank this year’s recipients for their support of the autism community and hope their groundbreaking work inspires others to follow in their footsteps.”

    The 8th annual Eagles Autism Challenge presented by Lincoln Financial will take place on Saturday, May 17, 2025. To register for the event, visit EaglesAutismChallenge.org. The Eagles Autism Foundation is offering a 50% discount on registration using promo code: LETSHUNT.

    For more information on the 2024 scientific review process and all the funded institutions, visit: EaglesAutismChallenge.org/our-impact-2024/.

    MIL OSI USA News

  • MIL-OSI USA: A Dose of History: Love is the Best Medicine

    Source: US State of Connecticut

     Cecily and Joe DiPiro: a Forever Type of Love  

    Picture this: UConn basketball season, 1975. You purchase your tickets for 50 cents apiece and head to the old fieldhouse, not yet knowing the glory of Gampel Pavilion. You and your date hit it off, and the rest is history!  

    For Cecily and Joe DiPiro, this is where their love story started. Their time at UConn began as freshmen in the School of Pharmacy, eager to dive into their passion. The following year, in January of 1975, they met while working at Yale New Haven Hospital. Amid conversation at the hospital, they realized they were in a few of the same classes together (nothing sparks love like organic chemistry). A month later, they were in that old fieldhouse on their first date. Cecily even has the ticket stub to prove it.  

    Over the next few years, Cecily and Joe’s passion grew as they fell in love with UConn. Their fondest memories include being proud members of AZO, a Professional Pharmaceutical Fraternity, and the Student Society of Hospital Pharmacists (CSHP). In addition to their pharmacy coursework, Cecily and Joe cheered on the Huskies during hockey games, skied down Horsebarn Hill when a small ski slope was still in operation, enjoyed the campus creamery, and embraced the UConn social scene, finding time to party amidst their busy schedules. During their time at UConn, Cecily and Joe were put in charge of a Beerfest, where they convinced faculty members to pour beer while raising money for the 1978 yearbook. They also went on a trip to Eli Lilly, riding a bus for 15 hours with their classmates to Indianapolis, where they received a two-day tour of the company. 

    Cecily and Joe DiPiro

    After their late-night study sessions and Beer Fests at UConn were over and Cecily and Joe graduated, they went into separate residency programs. Joe went to the University of Kentucky for his residency and Pharm.D. while Cecily went to Thomas Jefferson University Hospital in Philadelphia. After a year in each of their residency programs, they tied the knot while continuing their passion for pharmacy. Cecily worked as a hospital pharmacist at UK Medical Center until Joe graduated, and then they moved to the Augusta, GA area. Joe worked for the University of Georgia College of Pharmacy, while Cecily was a hospital pharmacist at the Medical College of Georgia Hospital. She spent most of her career as a hospital pharmacist, and in later years, worked as a diabetes coach and as a grants manager for the SC Pharmacy Association. Joe held leadership roles as Dean of South Carolina College of Pharmacy from 2005 to 2014 and Dean of Virginia Commonwealth University’s School of Pharmacy from 2014 to 2022. The pair also worked on several writing projects together. While busy with their professional careers, Joe and Cecily found time to raise their three children, one of whom is a pharmacist, and now are blessed with eight healthy and active grandchildren! 

    Cecily and Joe DiPiro

    After retiring from their successful careers, Cecily and Joe have found time to appreciate the connections they made early on in their lives at UConn’s School of Pharmacy. Looking back, they hold a special place in their hearts for the camaraderie they felt with their classmates and faculty during their journey at the School. Back in the ‘70s, when many UConn students would venture home on the weekends, the couple and their classmates would stay on campus and have the library to themselves, forming study groups and offering each other support and encouragement. “Our classmates were our day-to-day family,” says Cecily, reminiscing about heading to the old library with the Gold Dome roof to study with classmates. Joe added, “If you didn’t show up to class, they’d have the notes.” There might have been more than just studying at the old library, as Joe and Cecily recall four or five other couples in their class who eventually got married.  

    Although they haven’t been back to campus in several years, Cecily and Joe will always feel connected to their UConn family. Through exchanging Christmas cards or reconnecting in person at UConn reunions, they find ways to stay connected to their Husky roots, remembering the love they fostered for pharmacy and each other here at Storrs. 

    Bill and Erica Baker: From Lab Partners to Life Partners 

    Fast forward about twenty years from Cecily and Joe’s time at the UConn School of Pharmacy, and this is where Bill and Erica’s love story begins. Both attending E.O Smith High School near UConn, they began their story as lab partners in their senior year during advanced biology. They quickly realized they shared a common goal of attending UConn to pursue pharmacy. From running around the UConn campus during high school gym class to attending sporting events in the ‘80s long before they enrolled, Bill and Erica were excited to deepen the kinship they had felt with the university while growing up. 

    Bill and Erica Baker Celebrating Bill’s Graduation

    The following year, now at UConn as commuter students, the couple made it official.  Bill says their relationship grew naturally, bonding over the same Pre-Pharmacy classes and spending time at each other’s houses after class. During their sophomore year, Bill and Erica joined UConn’s professional pharmacy fraternity AZO and remained active members in the following years, and Bill now serves as the faculty advisor for the organization. Throughout their time at UConn, Bill and Erica developed their own friend groups, creating a strong network of friends and study partners. They continued their passion for pharmacy and gained experience, with Bill working at Walgreens and Erica in a hospital pharmacy. Despite being busy with their professional and academic careers, Bill and Erica found time to enjoy campus-wide events like Spring Weekend and concerts at Jorgensen. They also took part in classic UConn traditions, such as attending basketball games at Gampel.

    Bill and Erica Celebrating Erica’s Graduation

     Bill and Erica’s biggest relationship challenge came toward the end of their time at the School when Bill graduated in 2002 while Erica had one more year to complete. When Bill graduated, he accepted a post-pharmacy traineeship in Hartford. During this time, he lived with Erica, who was finishing up her last year at UConn. A month after Erica graduated in 2003, they married and moved to Delaware. Coordinating a wedding and a big move while Bill was employed and Erica was still finishing her degree was a challenge, but it was something the couple overcame. They eventually settled in Delaware, where Erica got a post-grad job. Despite the challenge, the couple felt relieved when they chose similar career paths, both wanting to work in a hospital setting so their schedules would align. 

    Bill and Erica Baker Present Day

    Now a faculty member, Bill strives to appreciate the opportunities he has as a UConn professor. He’s especially grateful for what he can give back to UConn: ‘The honor of being here, and giving back to the school and community that has meant so much to me.’ With three young children, Bill and Erica remain busy with their professional and personal lives but always make time to support their Husky family through watching and attending basketball and football games. Bill urges current UConn students in the School of Pharmacy to take every opportunity they are given, make connections, and never get too overwhelmed: ‘Obviously, you want to enjoy yourself.’ 

     We went to school here,” says Bill “We lived elsewhere for a period of time. And then now we’re back here.” Once a Husky, always a Husky! 

    MIL OSI USA News

  • MIL-OSI United Kingdom: Talk to someone if worried about mental wellbeing

    Source: Northern Ireland Direct

    Date published:

    Talk to someone if worried about your or someone else’s mental or emotional wellbeing. If in distress or despair, contact Lifeline on 0808 808 8000.

    Loneliness

    Loneliness can affect your mental and emotional wellbeing.

    Many people have experienced, or are experiencing, feelings of loneliness.

    Sometimes admitting you feel lonely is difficult.

    It’s important to try to connect with friends, family and communities, and to look out for those who may be experiencing loneliness.

    If you’re struggling and need to speak to someone, there are helplines on the Helplines NI website.

    Start a caring conversation

    Start a caring conversation with someone you’re concerned about. Let them know about that concern.

    Give them the space to explain what’s going on and how they’re feeling. 

    Offering a gentle word of support and listening in a non-judgemental way can make all the difference.

    Encourage them to tell their story in their own way and at their own pace. Let them know that you will support them to find the help that they need.

    By asking the questions ‘are you feeling a bit low?’ or ‘are you worried about something?’, you’re:

    • acknowledging their distress
    • giving them the chance to talk about something that is probably very frightening for them

    It’s even okay to ask someone if they have had thoughts about harming themselves or about suicide.

    Talking about how they’re feeling could be the first step towards recovery.

    You can find information on what you can say and do to help someone on this Public Health Agency leaflet

    Training courses 

    There are training courses available in:

    • mental and emotional wellbeing
    • suicide prevention

    You can find out more at this link:

    Recognising potential warning signs

    Mental health issues can affect anyone at any time of life and in different ways. 

    There are some early warning signs that may show mental ill-health or a mental health problem, including:

    • mood swings or a consistently lower mood
    • lack of care for personal appearance or personal responsibilities
    • increased use of alcohol or other drugs
    • a loss of interest in doing things they previously enjoyed
    • withdrawing from social activities or spending less time with family and friends
    • disturbed sleep, perhaps not getting enough sleep or sleeping too much
    • eating less than normal or overeating, perhaps losing or gaining weight
    • being more irritable, over-sensitive or aggressive
    • having difficulty following a conversation, remembering things or concentrating
    • experiencing repeated physical symptoms such as aches and pains or unexplained illnesses
    • a drop in work performance
    • doing things that don’t make sense to others
    • hearing or seeing things that no-one else can hear or see
    • talking about not wanting to live

    Someone having suicidal thoughts may not ask for help, but that doesn’t mean they don’t want help and support. It can be difficult finding the words to say how they’re feeling.

    You can find out more about what to do if you think someone might be in need of immediate help on the Mental health emergency – if you’re in crisis or despair page.

    You can find out more about mental health on these pages:

    In distress or despair – Lifeline

    If you or someone you know is in distress or despair, contact Lifeline on:

    This is a confidential service, where trained counsellors will listen and help immediately on the phone and follow up with other support if necessary.

    The helpline is available 24 hours a day, seven days a week.

    Take steps to improve your wellbeing

    By taking simple steps and introducing them into everyday life you can improve your mental health and wellbeing.

    Connect with people

    Spend time developing relationships with family, friends, colleagues and neighbours. 

    Be active

    Exercising can make you feel good, so find an activity that suits your mobility and fitness.

    Go for a walk or run, cycle, play a game, garden or dance.

    Take notice 

    Pause to look around you. What can you see, feel, smell or even taste?

    Look for beautiful, new, unusual or extraordinary things in your everyday life and think about how that makes you feel.

    Keep learning

    Try something new, sign up for a course or rediscover an old hobby.

    Set a challenge you will enjoy –  learning new things will make you more confident, as well as being fun to do.

    Give

    Do something nice for a friend or a stranger.

    Volunteer your time for a community group or charity.

    Seeing yourself, and your happiness, linked to the wider community can be incredibly rewarding and creates connections with the people around you.

    These can all lead to improving your wellbeing.

    More useful links

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: Celebrating World Pulses Day with Birmingham’s Full of Beans campaign

    Source: City of Birmingham

    Published: Thursday, 6th February 2025

    Tuesday 10th February marks World Pulses Day, a global awareness event promoting the importance of pulses, such as beans, lentils and chickpeas.

    Birmingham’s Public Health team is on a mission to help everyone discover just how amazing pulses are.  

    Pulses may be small, but they are mighty! They are packed full of protein, fibre, vitamins, and minerals, making them a nutritious addition to any meal, or a great snack for a boost of energy during the day. Their versatility means that they can be used in a wide variety of dishes and are a staple in many different cuisines.  

    They are also great for the planet because growing pulses helps to improve the quality of the soil, fewer greenhouse gases are released, and they use much less water compared to other sources of protein such as meat.  

    They can also help create nutritious meals that are affordable, particularly at a time when many households are concerned about the cost of living. 

    Birmingham Public Health is promoting the power of pulses through its Full of Beans campaign, which aims to increase the amount of beans and pulses eaten in schools, in families, and in food businesses.

    Under this initiative, and as World Pulses Day approaches, the team has created a feast of activities and resources, including booklets and online information, to help people discover, explore and celebrate beans and pulses through growing, tasting and cooking. Recipe ideas are also available via the Full of Beans communities on the Samsung Food app here.

    Keep an eye for further information, including activities and recipes, via Birmingham Public Health’s Healthy Brum social media channels on World Pulses Day itself.

    Further information on the Full of Beans campaign can be found here.

    MIL OSI United Kingdom

  • MIL-OSI Europe: AFRICA/BURKINA FASO – Appointment of the Bishop of Tenkodogo

    Source: Agenzia Fides – MIL OSI

    Thursday, 6 February 2025

    Vatican City (Agenzia Fides) – The Holy Father has appointed Rev. Fr. David Koudougou, of the clergy of Tenkodogo, until now Diocesan Administrator of the same Diocese, as Bishop of the Diocese of Tenkodogo.His Exc. Msgr. David Koudougou, was born on 1 August 1972 in Tenkodogo and completed his studies in Philosophy and Theology at the Saint Jean Baptiste de Wayalghin Major Seminary in Ouagadougou.He was ordained a priest on 14 July 2001.He has held the following positions and completed further studies: Parish Vicar of the Sacred Heart in Garango (2001-2002); Parish Vicar of Boussouma (2002-2006); Professor of Canon Law and Homiletics at the Saint Pierre Claver de Koumi Major Seminary (2009-2013); Doctorate in Canon Law at the Pontifical Gregorian University in Rome (2013-2016); Parish Vicar of Saint Paul of Moaga, Official of the Metropolitan Tribunal of Koupèla; member of the College of Consultors of the Metropolitan Archdiocese of Koupèla, Secretary General of the Episcopal Commission for Ecclesiastical Tribunals and Legal Affairs of the Episcopal Conference, Episcopal Delegate to the Diocesan Council of Catholic Education of the Diocese of Tenkodogo (2017-2023).Since 2023 he has been an Official of the Ecclesiastical Tribunal and member of the College of Consultors of the Diocese of Tenkodogo and Diocesan Administrator of Tenkodogo. (EG) (Agenzia Fides, 6/2/2025)
    Share:

    MIL OSI Europe News

  • MIL-OSI Security: Appeal to find missing man Paul Merrett

    Source: United Kingdom London Metropolitan Police

    Police are appealing for the public’s help to find Paul Merrett, 28 who is missing from Woolwich.

    Paul was last seen leaving Greenwood House Memorial Hospital on Wednesday, 22 January. It’s possible that he then got onto a bus towards Shooters Hill.

    He is described as a white man, of a slim build with brown hair. He was last seen wearing a black jacket, a black jumper, blue jeans and light blue crocs.

    He has connections to Croydon.

    Officers are carrying out multiple enquiries to locate Paul and appealing to anyone who may have seen him to get in contact.

    Paul is vulnerable and members of the public are asked to contact the police directly rather than attempt to engage with him.

    Anyone with information is asked to call police on 101 or post @MetCC ref CAD 2704/22JAN25.

    To remain 100% anonymous contact the independent charity Crimestoppers on 0800 555 111.

    MIL Security OSI

  • MIL-OSI: Solum Global Inc. Announces U.S. Healthcare Collaboration and Licensing Agreement with AI Company Life2, Inc.

    Source: GlobeNewswire (MIL-OSI)

    WEST PALM BEACH, FL, Feb. 06, 2025 (GLOBE NEWSWIRE) — Solum Global Inc. (“Solum Global, Solum or the Company”) a transparent digital network with a fully decentralized, permissionless blockchain protocol and stablecoin (sgUSD) for storing, trading, and transferring digital and real-world assets enabling immediate settlement between individuals, businesses, and governments, announced today a collaboration and licensing agreement with Artificial Intelligence company Life2, Inc., to address fraud, waste, abuse and other financial inefficiencies in the U.S healthcare industry.

    “Solum Global and Life2 are redefining the future of healthcare finance by driving smarter, data-backed decision-making and unlocking new levels of operational excellence. This partnership transforms financial operations by integrating Life2’s predictive AI analytics with Solum’s blockchain-based RCM solution—reducing billing errors, detecting fraud, and optimizing workflow outcomes. With real-time insights, providers can improve forecasting, enhance cash flow, and streamline administration,” stated Sterling Griffin, Vice President and Co-Founder of Solum Global Inc.

    The U.S. healthcare system faces mounting inefficiencies, rising costs, and security risks, making innovation imminent. The National Health Care Anti-Fraud Association estimates the annual cost of healthcare accounts for an estimated 3% to 10% of all expenditures, totaling between $147 billion and $490 billion annually. Meanwhile, data breaches remain a persistent threat, routinely exposing sensitive personal information. In 2023 alone, the Department of Health and Human Services (HHS) Office for Civil Rights (OCR) published that 725 breaches compromised over 133 million records across healthcare and insurance companies. Partnering with Life2, Inc. means harnessing the power of AI-driven analysis to uncover hidden financial inefficiencies in historical medical records. By leveraging deep domain expertise, large-scale data sets, advanced modeling techniques, and AI-driven machine learning, Life2 tackles complex market challenges beyond the reach of human problem-solving. This partnership empowers providers, hospitals, and insurers to detect billing errors, waste, and fraud while accurately predicting and optimizing future medical expenditures, driving smarter financial and operational decisions.

    “We are excited to collaborate with Solum Global to tackle the deep-rooted challenges within the U.S. healthcare system. By highlighting continual and substantial losses caused by financial leakage and actively partnering with the Solum team on their seamless, end-to-end solution, we are helping drive meaningful change. Together, we are working to reshape American healthcare by reducing costs for patients, providers, and payers,” said Rick Egan, CEO of Life2, Inc.

    Solum Global is revolutionizing U.S. healthcare by integrating Artificial Intelligence (AI), smart contracts, and its stablecoin (sgUSD) with a proprietary electronic health wallet (EHW) slated for release in Q2 2025. This blockchain-powered web3 platform modernizes revenue cycle management (RCM), replacing outdated web2 systems with a seamless, secure, and automated solution. By leveraging blockchain’s programmability, security, immutability, and smart contract billing, Solum facilitates instant payments through the EHW using sgUSD, a U.S. dollar-backed stablecoin. The Solum Global electronic health wallet addresses these challenges by providing a secure, blockchain-powered solution that streamlines transactions, reduces fraud, and enhances data protection. By providing individuals with greater control over their health information, Solum Global is setting a new standard for security and efficiency in healthcare.

    About Solum Global Inc.
    Solum Global is a transparent digital network with a fully decentralized, permissionless blockchain protocol for storing, trading, and transferring digital and real-world assets, enabling immediate settlement between individuals, businesses, and governments. Utilizing cutting-edge blockchain technology, Artificial Intelligence (AI), smart contracts, the Company’s stablecoin (sgUSD), and a proprietary electronic health wallet (EHW), Solum Global provides a seamless solution that addresses the significant challenges inherent in the U.S. healthcare industry. For more information, visit  www.solum.global.

    About Life2, Inc.
    Life2’s core Intellectual Property utilizes deep domain expertise in the use of AI, machine learning, large-scale data sets, and advanced analytics to address complex market needs that cannot be addressed by human problem-solving. Specializing in outcome analytics – proprietary technology that sits at the apex of data analysis, Life2 aggregates, organizes, and analyzes data to provide continuous, real-time, per-person, and per-event risk and intervention analysis that optimizes desired future outcomes. Outcomes can be financial, operational, clinical, or any other type of target metric across all sectors of the healthcare market. For more information, visit https://www.life2inc.com/.

    Forward-Looking Statements 
    Certain statements in this press release constitute “forward-looking statements” within the meaning of the federal securities laws.  Words such as “may,” “might,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,” “plan,” “intend” or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements.  These forward-looking statements are based upon current estimates and assumptions. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release.  These forward-looking statements are subject to various risks and uncertainties, including without limitation those set forth in the Company’s filings with the Securities and Exchange Commission. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

    Contacts:

    Investor Relations
    Hanover International
    ka@hanoverintlinc.com

    Media Contact
    media@solum.global

    The MIL Network

  • MIL-OSI United Nations: Gaza: 10,000 aid trucks reached enclave since ceasefire began

    Source: United Nations 4

    Humanitarian Aid

    The humanitarian community’s plan to flood Gaza with lifesaving aid passed an important milestone on Thursday with the news that more than 10,000 relief lorries have entered the enclave since the ceasefire began on 19 January.

    Announcing the development, the UN’s top aid official, Tom Fletcher, said that the trucks contained lifesaving food, medicine, and tents – all desperately needed by Gazans after more than 15 months of constant Israeli bombardment.

    The UN emergency relief chief’s comments came as he prepared to join an aid convoy crossing into northern Gaza.

    In recent days, he has held “practical discussions” with the Israeli authorities in Tel Aviv and Jerusalem “to keep lifesaving UN aid moving into Gaza at scale”. This includes COGAT – the Israeli body responsible for approving requests to deliver aid into Gaza and the West Bank – and the Israel Foreign Ministry.

    Clearing rubble to live

    According to the UN aid coordination office, OCHA, more than half a million people have returned to north Gaza since the ceasefire began. Needs for food, water, sanitation, healthcare and tents are enormous, with some returning to former homes with shovels to clear the rubble, according to the UN Children’s Fund, UNICEF.

    In an update, the UN World Health Organization (WHO), said that it had received 63 trucks of medical supplies from aid partners to replenish its three warehouses in Gaza.

    In addition, more than 100 sick and injured patients have also been evacuated to Egypt for urgent medical treatment since the temporary ceasefire came into effect, while OCHA noted that primary and secondary health services are being provided throughout the Strip.

    Five ambulances entered Gaza to strengthen emergency response capacity on Tuesday, OCHA said in an update.

    Food production boosted

    The UN aid coordination agency noted that across Gaza, 22 bakeries supported by the World Food Programme (WFP) are now operational.

    The WFP has also provided nutrient supplements to more than 80,000 children and pregnant or breastfeeding women across Gaza, since the ceasefire took effect and UNICEF has continued distributing nutrition support for infants.

    Humanitarian partners have screened more than 30,000 children under the age of five for malnutrition since the ceasefire took effect. Of those screened, 1,150 cases of acute malnutrition have been identified, including 230 cases of severe acute malnutrition,” OCHA said.

    In addition, the UN Food and Agriculture Organization (FAO) distributed nearly 100 metric tons of animal feed to support herders in Deir al Balah and Khan Younis, benefiting hundreds of people working in the agricultural sector.

    To sustain learning activities across the Strip, education partners have established three new temporary learning spaces yesterday in Gaza, Rafah and Khan Younis governorates, benefiting 200 school-aged children.

    Ceasefire push 

    The aid build-up came as the Secretary-General on Wednesday pushed for a permanent ceasefire in Gaza and the release of all remaining hostages in the enclave, while strongly rejecting the suggestion that Gazans should be resettled outside their homeland.

    “In the search for solutions, we must not make the problem worse. It is vital to stay true to the bedrock of international law. It is essential to avoid any form of ethnic cleansing,” Guterres told  the UN Committee on the Exercise of the Inalienable Rights of the Palestinian People, which met to set out its programme of work for the year. “We must reaffirm the two-State solution,” he said.

    Underlining the Secretary-General’s comments, the UN High Commissioner for human rights, Volker Türk, said that “any deportation or forced transfer of persons without legal basis is strictly forbidden”.

    MIL OSI United Nations News

  • MIL-OSI: Applied Releases Commercial Lines Premium Rate Index Findings for Year-End and Q4 2024

    Source: GlobeNewswire (MIL-OSI)

    Toronto, ON., Feb. 06, 2025 (GLOBE NEWSWIRE) — Applied Systems® today announced the final quarter 2023 results of the Applied Commercial Index™, the Canadian insurance industry’s premium rate index. Overall, the magnitude of rate increases was down across all lines relative to average premium renewals in the same quarter last year with 5.02% in Q4 2024, down from 7.55% in Q4 2023. All lines of business saw decreases compared to the same quarter last year.

    Quarter over quarter, Q4 2024 results showed average renewal rate change decreased across all lines of the most commonly placed Commercial Lines categories, including Real Estate Property, Construction, Hospitality Services, and Retail Services, with the exception of Business and Professional Services which experienced a slight quarterly increase.

    Significant findings include:

    • Business and Professional Services: Q4 2024 premium renewal rate change average was 5.48%, up from the Q3 2024 average of 5.30%.
    • Construction, Erection, and Installation Services: Premium renewal rate change average was 4.78% for the quarter, down from the Q3 2024 average of 5.36%.
    • Hospitality Services: Q4 2024 premium renewal rate change average was 3.79%, down from the Q3 2024 average of 5.77%.
    • Real Estate Property: Premium renewal rate change average was 4.59% for the quarter, down from the Q3 2024 average of 5.32%.
    • Retail Services: Premium renewal rate change averaged 6.84%, down relative to the Q3 2024 average of 7.53%.

    “This quarter’s results demonstrate a continued softening of the commercial lines market as premium renewal rates decrease quarter over quarter and compared to the average of last year’s same quarter,” said Steve Whitelaw, senior vice president and general manager, Canada, Applied Systems. “As we enter 2025, we will continue to watch as macro trends, such as increased competition in the commercial lines market, continues to impact rates.” 

    Access the complete quarterly report here.

    # # #

     Applied Commercial Index is a trademark of Applied Systems, Inc. All data is fully anonymized when aggregating and analyzing the Applied Commercial Index.

    About Applied Systems
    Applied Systems is the leading global provider of cloud-based software that powers the business of insurance. Recognized as a pioneer in insurance automation and the innovation leader, Applied is the world’s largest provider of agency and brokerage management systems, serving customers throughout the United States, Canada, the Republic of Ireland, and the United Kingdom. By automating the insurance lifecycle, Applied’s people and products enable millions of people around the world to safeguard and protect what matters most.

    The MIL Network

  • MIL-OSI: Traliant elevates workplace safety with new training on psychological safety and workplace violence prevention for healthcare

    Source: GlobeNewswire (MIL-OSI)

    NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) — Traliant, a leader in online compliance training, today announced the launch of two new training courses designed to enhance workplace safety. Psychological Safety at Work and Workplace Violence Prevention for Healthcare empower employers to protect the physical and mental well-being of their employees, enabling them to perform at their best.

    “For employees to bring their best selves to work, they need to feel both psychologically and physically safe,” said Mike Dahir, CEO of Traliant. “Training in these critical areas helps reduce employee stress and fosters positive work environments where individuals feel valued and protected.”

    Organizations that prioritize psychological safety lay the groundwork for innovation, adaptability, and resilience in the face of change. Traliant’s Psychological Safety at Work training helps employees feel confident in expressing diverse viewpoints, challenging assumptions, and taking risks with new ideas — without fear of repercussions — encouraging creativity and innovation.

    Workplace safety is a pressing concern for healthcare workers, who are significantly more likely to experience workplace violence than those in other industries due to stressed patients, frustrated visitors and overwhelmed employees. Traliant’s Workplace Violence Prevention for Healthcare training equips healthcare professionals with the skills to recognize early warning signs of violence, de-escalate tense situations, and protect themselves and others.

    The healthcare course not only helps employers reduce physical and emotional harm to their workforce, but it also ensures compliance with regulatory requirements and industry standards. The course complies with the workplace violence prevention training requirements applicable to specific healthcare employers in Arizona, California, Louisiana, Minnesota, and Texas. Traliant also offers a California version designed to comply with California’s workplace violence prevention law (SB 533/Cal. Lab. Code 6401.9).

    To learn more about Traliant, visit: https://www.traliant.com/.

    About Traliant
    Traliant, a leader in compliance training, is on a mission to help make workplaces better, for everyone. Committed to a customer promise of “compliance you can trust, training you will love,” Traliant delivers continuously compliant online courses, backed by an unparalleled in-house legal team, with engaging, story-based training designed to create truly enjoyable learning experiences.

    Traliant supports over 14,000 organizations worldwide with a library of curated essential courses to broaden employee perspectives, achieve compliance and elevate workplace culture, including sexual harassment trainingdiversity trainingcode of conduct training, and many more.  

    Backed by PSG, a leading growth equity firm, Traliant holds a coveted position on Inc.’s 5000 fastest-growing private companies in America for four consecutive years, along with numerous awards for its products and workplace culture. For more information, visit http://www.traliant.com and follow us on LinkedIn.

    Contact
    Reagan Bennet
    traliant@v2comms.com 

    The MIL Network

  • MIL-OSI Global: What Los Angeles-area schools can learn from other districts devastated by natural disasters

    Source: The Conversation – USA – By Lee Ann Rawlins Williams, Clinical Assistant Professor of Education, Health and Behavior Studies, University of North Dakota

    Eliot Arts Magnet Middle School burned when the Eaton Fire swept through Altadena, Calif., in January 2025. JOSH EDELSON/AFP via Getty Images

    As Los Angeles County students begin returning to school after wildfires devastated the region, it’s worth examining how other U.S. educational systems disrupted by natural disasters have moved forward.

    Many students and educators have experienced the loss of their schools and homes, leaving them with a deep sense of grief and uncertainty. More than 1,000 schools were closed in Los Angeles County due to the fires, affecting more than 600,000 students across 26 districts.

    But loss during a disaster goes beyond what’s visible. And a return to normalcy means more than rebuilding schools and educational spaces.

    The fires have disrupted learning, emotional well-being and the routines that hold educational communities together. Previous disasters show that the emotional recovery of students and teachers needs attention for academic progress to be effective.

    As a professor who has studied how educational systems recover from natural disasters, I think Los Angeles-area schools will have to address some key themes of loss as they recover from the fires.

    Loss of learning time and continuity

    One educational consequence after natural disasters is loss of learning time and continuity. After previous natural disasters, some school districts stressed the importance of returning to in-person instruction quickly.

    For example, the Florida Department of Education reported in October 2022 that 68 of the state’s 75 school districts were open one week after Hurricane Ian barreled through the state.

    But that’s not always the best decision.

    Students often need time and space to process loss. Rushing students back into class without acknowledging this can feel counterproductive.

    Successful responses to large-scale disruptions show that keeping education on track during such times requires a holistic approach that involves the entire community.

    Schools play a crucial role in this approach. Beyond offering educational continuity, they are spaces where students can find support and stability.

    This doesn’t necessarily mean an immediate return to the classroom. Instead, a holistic approach ensures that when students do return to school, they have the necessary emotional and psychological support in place.

    In the wake of Hurricane Helene in September 2024, for example, school districts recognized that emotional healing is essential before academic recovery can begin.

    Fifty-three school districts across North Carolina sent 263 counselors and social workers to support students and educators in Buncombe County, home to Asheville, after Helene.

    Soon afterward, teachers incorporated hurricane recovery efforts into their lesson plans. When an environmental response team helped schools use portable testing kits for water quality analysis, some science teachers incorporated the hands-on learning into their classrooms.

    The experience allowed students to engage in a real-world application of science. This deepened their understanding of the disaster’s health impact.

    The Eaton Fire burned the Aveson School of Leaders elementary school in Altadena, Calif., in January 2025.
    Sarah Reingewirtz/MediaNews Group/Los Angeles Daily News via Getty Images

    After Hurricane Milton swept through Tampa Bay, Fla., schools in Hillsborough County extended the first-quarter grading period. They also reviewed the academic calendar to determine necessary adjustments for making up lost instructional time.

    Meanwhile, Pinellas County Schools, which also serves the Tampa Bay area, deployed a mental health and wellness plan developed in 2022 to support students and staff. It emphasizes the need for both academic recovery and mental health support.

    For Los Angeles-area students and teachers, a similar approach could involve offering mental health counseling and creating safe spaces for students and educators to process trauma. This can be done via drop-in counseling collaborations between community mental health providers and trained professionals in schools.

    These efforts could support resilience and long-term recovery.

    New environments and challenges

    The Los Angeles-area wildfires have destroyed schools that often provide free or reduced lunch services to many students. The fires have also uprooted many students, forcing them to navigate new and unfamiliar schools.

    Educators, meanwhile, must manage the challenges of teaching in temporary settings with limited resources.

    These strains highlight the urgent need for support systems to promote stability and rehabilitation.

    Teacher Adrianna Vargas prepares a classroom at Woodbury Village Preschool for the return of students after the Eaton Fire in Altadena, Calif., on Jan. 22, 2025.
    Genaro Molina/Los Angeles Times via Getty Images

    Schools can implement flexible deadlines for assignments to accommodate students dealing with transitional living situations and limited access to resources. Adjusting school grading can provide more realistic measures of student progress during periods of disruption.

    This reduces pressure on students and teachers alike.

    Flexible learning schedules – such as hybrid models combining remote and in-person studies – and staggered school hours can help students stay engaged in their education while they adapt to new circumstances.

    A vision for the future

    Schools often serve as pillars of support. They can be safe havens that provide stability.

    Their recovery is closely tied to broader community rebuilding efforts.

    However, the extent to which this occurs may vary depending on the resources and collaboration between local governments, educational leaders and community members, research shows.

    The process is most effective when there is a coordinated effort – one that acknowledges the emotional and social needs of all involved.

    By acknowledging the profound impact of loss, Los Angeles County can rebuild an educational system that is compassionate and honors shared experiences, while promoting healing, learning and community renewal.

    Lee Ann Rawlins Williams does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

    ref. What Los Angeles-area schools can learn from other districts devastated by natural disasters – https://theconversation.com/what-los-angeles-area-schools-can-learn-from-other-districts-devastated-by-natural-disasters-247777

    MIL OSI – Global Reports

  • MIL-OSI Global: US dodged a bird flu pandemic in 1957 thanks to eggs and dumb luck – with a new strain spreading fast, will Americans get lucky again?

    Source: The Conversation – USA – By Alexandra M. Lord, Chair and Curator of Medicine and Science, Smithsonian Institution

    Eggs have been crucial to vaccine production for decades. Bettmann/Getty Images

    In recent months, Americans looking for eggs have faced empty shelves in their grocery stores. The escalating threat of avian flu has forced farmers to kill millions of chickens to prevent its spread.

    Nearly 70 years ago, Maurice Hilleman, an expert in influenza, also worried about finding eggs. Hilleman, however, needed eggs not for his breakfast, but to make the vaccines that were key to stopping a potential influenza pandemic.

    Hilleman was born a year after the notorious 1918 influenza pandemic swept the world, killing 20 million to 100 million people. By 1957, when Hilleman began worrying about the egg supply, scientists had a significantly more sophisticated understanding of influenza than they had previously. This knowledge led them to fear that a pandemic similar to that of 1918 could easily erupt, killing millions again.

    As a historian of medicine, I have always been fascinated by the key moments that halt an epidemic. Studying these moments provides some insight into how and why one outbreak may become a deadly pandemic, while another does not.

    Anticipating a pandemic

    Influenza is one of the most unpredictable of diseases. Each year, the virus mutates slightly in a process called antigenic drift. The greater the mutation, the less likely that your immune system will recognize and fight back against the disease.

    Every now and then, the virus changes dramatically in a process called antigenic shift. When this occurs, people become even less immune, and the likelihood of disease spread dramatically increases. Hilleman knew that it was just a matter of time before the influenza virus shifted and caused a pandemic similar to the one in 1918. Exactly when that shift would occur was anyone’s guess.

    In April 1957, Hilleman opened his newspaper and saw an article about “glassy-eyed” patients overwhelming clinics in Hong Kong.

    The article was just eight sentences long. But Hilleman needed only the four words of the headline to become alarmed: “Hong Kong Battling Influenza.”

    Within a month of learning about Hong Kong’s influenza epidemic, Hilleman had requested, obtained and tested a sample of the virus from colleagues in Asia. By May, Hilleman and his colleagues knew that Americans lacked immunity against this new version of the virus. A potential pandemic loomed.

    The U.S. prioritized vaccinating military personnel over the public in 1957. Here, members of a West German Navy vessel hand over a jar of vaccine to the U.S. transport ship General Patch for 134 people sick with flu.
    Henry Brueggemann/AP Photo

    Getting to know influenza

    During the 1920s and 1930s, the American government had poured millions of dollars into influenza research. By 1944, scientists not only understood that influenza was caused by a shape-shifting virus – something they had not known in 1918 – but they had also developed a vaccine.

    Antigenic drift rendered this vaccine ineffective in the 1946 flu season. Unlike the polio or smallpox vaccine, which could be administered once for lifelong protection, the influenza vaccine needed to be continually updated to be effective against an ever-changing virus.

    However, Americans were not accustomed to the idea of signing up for a yearly flu shot. In fact, they were not accustomed to signing up for a flu shot, period. After seeing the devastating impact of the 1918 pandemic on the nation’s soldiers and sailors, officials prioritized protecting the military from influenza. During and after World War II, the government used the influenza vaccine for the military, not the general public.

    Stopping a pandemic

    In the spring of 1957, the government called for vaccine manufacturers to accelerate production of a new influenza vaccine for all Americans.

    Traditionally, farmers have often culled roosters and unwanted chickens to keep their costs low. Hilleman, however, asked farmers to not cull their roosters, because vaccine manufacturers would need a huge supply of eggs to produce the vaccine before the virus fully hit the United States.

    But in early June, the virus was already circulating in the U.S. The good news was that the new virus was not the killer its 1918 predecessor had been.

    Hoping to create an “alert but not an alarmed public,” Surgeon General Leroy Burney and other experts discussed influenza and the need for vaccination in a widely distributed television show. The government also created short public service announcements and worked with local health organizations to encourage vaccination.

    A 1957 film informing Americans how the U.S. was responding to an influenza outbreak.

    Vaccination rates were, however, only “moderate” – not because Americans saw vaccination as problematic, but because they did not see influenza as a threat. Nearly 40 years had dulled memories of the 1918 pandemic, while the development of antibiotics had lessened the threat of the deadly pneumonia that can accompany influenza.

    Learning from a lucky reprieve

    If death and devastation defined the 1918 pandemic, luck defined the 1957 pandemic.

    It was luck that Hilleman saw an article about rising rates of influenza in Asia in the popular press. It was luck that Hilleman made an early call to increase production of fertilized eggs. And it was luck that the 1957 virus did not mirror its 1918 relative’s ability to kill.

    Recognizing that they had dodged a bullet in 1957, public health experts intensified their monitoring of the influenza virus during the 1960s. They also worked to improve influenza vaccines and to promote yearly vaccination. Multiple factors, such as the development of the polio vaccine as well as a growing recognition of the role vaccines played in controlling diseases, shaped the creation of an immunization-focused bureaucracy in the federal government during the 1960s.

    Inoculating eggs with live virus was the first step to producing a vaccine.
    AP Photo

    Over the past 60 years, the influenza virus has continued to drift and shift. In 1968, a shift once again caused a pandemic. In 1976 and 2009, concerns that the virus had shifted led to [fears that a new pandemic loomed]. But Americans were lucky once again.

    Today, few Americans remember the 1957 pandemic – the one that sputtered out before it did real damage. Yet that event left a lasting legacy in how public health experts think about and plan for future outbreaks. Assuming that the U.S. uses the medical and public health advances at its disposal, Americans are now more prepared for an influenza pandemic than our ancestors were in 1918 and in 1957.

    But the virus’s unpredictability makes it impossible to know even today how it will mutate and when a pandemic will emerge.

    Alexandra M. Lord does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

    ref. US dodged a bird flu pandemic in 1957 thanks to eggs and dumb luck – with a new strain spreading fast, will Americans get lucky again? – https://theconversation.com/us-dodged-a-bird-flu-pandemic-in-1957-thanks-to-eggs-and-dumb-luck-with-a-new-strain-spreading-fast-will-americans-get-lucky-again-247157

    MIL OSI – Global Reports

  • MIL-OSI Global: How populist leaders like Trump use ‘common sense’ as an ideological weapon to undermine facts

    Source: The Conversation – USA – By Dannagal G. Young, Professor of Communication and Political Science, University of Delaware

    Secretary of Defense Pete Hegseth, left, is part of a ‘revolution of common sense’ led by President Donald Trump. Chip Somodevilla/Getty Images

    It’s “the revolution of common sense,” President Donald Trump announced in his second inaugural address.

    And so it is. The latest installment of that assertion came in his Jan. 30, 2025, press conference about the Potomac plane crash. When asked how he had concluded that diversity policies were responsible for a crash that was still under investigation, Trump responded, “Because I have common sense, OK?”

    “Common sense” is what’s known to scholars as a “lay epistemology,” or how regular people make sense of the world. We don’t rely on statistical evidence or expert research while we’re buying lettuce or driving in traffic. Instead, we’re guided by direct experience, emotions and intuition.

    Because it comes from regular people and not institutions that some people deem to be “corrupt,” champions of common sense suggest it leads to a purer form of truth.

    President Donald Trump is asked how he could conclude that DEI policies caused the Potomac plane crash.

    Yet it is precisely because it comes from personal observations and intuition that research shows common sense is steeped in bias and often leads us astray.

    Populist leaders like Trump commonly celebrate common sense and attack expertise and evidence. Populism is less about being liberal or conservative than it is a way of appealing to the public. These appeals are based on a moral separation between the corrupt, bad people with cultural power and the good, pure people who hold the right values – like faith in common sense over expertise and evidence.

    And with the new Trump administration, the elevation of common sense as a virtue has been quick and broad.

    Dusty boots vs. elite credentials

    In his confirmation hearing for the position of secretary of defense, Pete Hegseth pointed to “dust on his boots” as evidence of his qualifications, in contrast to the elite credentials of past defense secretaries, who have often been Washington insiders.

    Hegseth couldn’t name members of the Association of Southeast Asian Nations, an alliance of countries playing a crucial role in global security. But he did show that he knew the diameter of the rounds that fit in the magazine of an M4 rifle.

    That was evidence that he was, in his words, “a change agent. Someone with no vested interest in certain companies or specific programs or approved narratives.”

    Even Meta’s announcement that it would roll back expert fact-checking on its U.S. social media platforms reflects a “lay epistemic” shift.

    Meta explained that fact-checkers, “like everyone else, have their own biases and perspectives” and that these biases had made fact-checking “a tool to censor.”

    Instead, the company would embrace a community notes model where users could provide additional information on posts, which Meta argued would be “less prone to bias.”

    We’ve seen this approach work on X,” wrote Meta’s Chief Global Affairs Officer Joel Kaplan, “where they empower their community to decide when posts are potentially misleading and need more context, and people across a diverse range of perspectives decide what sort of context is helpful for other users to see.”

    This policy change is probably less of a shift in Facebook founder and CEO Mark Zuckerberg’s principles than a change made out of necessity. Given Trump’s penchant for falsehoods, I imagine Meta’s previous policy would soon have proved financially and politically inconvenient.

    Regardless, the result is a populist’s dream: the demotion of formal expertise in favor of “common sense.”

    When asked whether he knew the members of a regional security alliance, defense secretary nominee Pete Hegseth was stumped.

    Common sense is ideological

    For the past two decades, the rise in social media, combined with declining trust in formal news organizations, has democratized knowledge: the sense that no one person or institution has special access to truth – not scholars with many degrees, not experts armed with scientific evidence or data, and definitely not journalists.

    In a 2020 study of public sentiment across 20 countries, Pew Research Center found that the overwhelming majority of those surveyed, 66%, reported trusting people with “practical experience” to solve problems over experts. Only 28% trusted the experts to solve problems.

    If institutions and experts are perceived as corrupt and ideological, the only truth that we can trust is what comes from our own eyes and our own minds.

    But does common sense bring us to truth? Sometimes, yes. It’s also appealing: Since our observations of the world are informed by our values and beliefs, we often see what we want – such as diversity-hiring initiatives known as “DEI” causing a plane crash, for example.

    And our intuition rarely tells us we’re wrong. This helps account for the existence of confirmation bias, which is our tendency to see and remember things that tell us we’re right. This is also why, even in those rare instances when facts change minds, they rarely change hearts. If we do update our knowledge with correct information, research has shown that our gut will still tell us our overall view of the world was right.

    Ironically, studies also show that the more a person trusts common sense, the more likely they are to be wrong.

    My research has shown that the people most likely to believe misinformation about COVID-19 and the 2020 election were those who placed more trust in intuition and emotion, and less trust in evidence and data. In addition, the more people liked Donald Trump, the more they valued intuition and emotion – and rejected evidence and data.

    So, common sense is ideological.

    When our pathway to knowledge is limited by our experiences and intuition, we’re not actually looking for truth. We’re happy with whatever answers are available, including conspiracy theories or explanations that make us feel good and right.

    We blame individuals – especially people we don’t like or identify with – for their own misfortune. We tend to think “those people should be better and try harder” instead of looking for public policy solutions to problems such as poverty or drug addiction. Without evidence and data summarizing large trends – such as cancer rates tracked through National Institutes of Health funding or ocean temperatures tracked by National Science Foundation funding – we are limited to what we can see through our own eyes and biases.

    And our limited observations merely reinforce our underlying beliefs: “My neighbor probably has breast cancer from taking that medicine I don’t like” or “Today is probably just a randomly hot day.” We’ll either overgeneralize from or downplay these limited examples depending on what our “common sense” says.

    So, when populists elevate common sense as a virtue, it’s not just to celebrate how regular people understand the world. It’s to promote a worldview that rejects verifiable facts, exaggerates our biases, and paves the way for even more propaganda to come.

    Dannagal G. Young was a co-investigator on an NIH grant that provided funding for one of the studies referenced in this piece.

    ref. How populist leaders like Trump use ‘common sense’ as an ideological weapon to undermine facts – https://theconversation.com/how-populist-leaders-like-trump-use-common-sense-as-an-ideological-weapon-to-undermine-facts-248608

    MIL OSI – Global Reports

  • MIL-OSI United Kingdom: NFU Scotland conference 2025 – UK Government keynote address

    Source: United Kingdom – Executive Government & Departments 2

    Today (Thursday, 6 February) UK Government Scotland Office Minister Kirsty McNeill spoke at the NFU Scotland conference in Glasgow.

    Good morning everyone, thank you for inviting me to be here with you today. I’d like to thank Martin Kennedy for that kind introduction and congratulate him for his work in leading the NFUS as he finishes his term as your President.

    I’d also like to start with a huge thanks for your dedicated work in continuing to produce, gather and distribute top quality food across the whole of the UK. But more than that, thank you to all farmers and crofters for the central role you play in our national life and heritage in Scotland.

    Despite countless challenges – not least the famous Scottish climate – farmers continue to work tirelessly, day after day, to feed the United Kingdom, and further afield.

    And be in no doubt, the UK Government will continue to do our part in supporting Scottish farmers and crofters, who form such a central part of our rural and island communities.

    Of course, the majority of environmental policy is devolved, with agriculture policy fully devolved. We will continue to respect the devolution settlement and strengthen relations with the Scottish Government as part of our ongoing resetting of relations.

    But there is much we can and are doing for farming and rural communities more broadly through our Plan for Change to turbo-charge economic growth and deliver a decade of national renewal and opportunity for all.

    Now, let’s be real. I know what you want to ask me about today. And I know that you’re angry. So I’m not going to shy away from a conversation about APR. But I do want to contextualise it. It’s the job of the NFU to make the case for your members. And it’s the job of the UK Government to listen, yes, but to also take a broad and long term view, balancing competing perspectives.

    And the facts are these. The UK Government’s Autumn Budget last year delivered the largest settlement for the Scottish Government in the history of devolution.

    The Chancellor announced on 30 October an additional £1.5 billion for the Scottish Government to spend in this financial year, and an additional £3.4 billion in the next.

    The Scottish Government will be able to allocate this record funding to devolved areas, including agriculture and rural communities. And that does mean your interests will be weighed alongside other devolved policy areas – that’s devolution in action. But I hope you will also see the benefit to your members of this record investment we’ve made available for Scotland’s public services. Because you know better than anyone that our farming communities are too often the ones with the worst access to NHS services. Public transport is sparse or non-existent. Cuts to schools and local services often hit your families harder than those in our big cities. I’m proud of this investment into the Scottish Government and I hope you will come to be too.

    And where policy is reserved, such as in relation to immigration or international trade, we will help support the industry through continuous engagement and development of policy. This is how devolution should work, and we are determined that it does.

    Our new Food Strategy will deliver clear long-term outcomes that create a healthier, fairer, and more resilient food system. We will work together with the Scottish government to complement the progress that they have already made in this area.

    Russia’s illegal invasion of Ukraine sent shock waves across the global supply chain, and the price of fertilisers and energy bills skyrocketed. That is one reason why we have launched our Clean Power 2030 Action Plan. By sprinting towards clean, homegrown energy, we will protect our energy security from international shocks, create thousands of good quality jobs, tackle climate change and drive down bills for good.

    We are taking some bold steps, including by setting up Great British Energy. This new, homegrown energy company – headquartered here in Scotland – will provide a catalyst for new, clean energy projects across the UK.

    Unpredictable weather has been causing floods and droughts as the climate continues to change, directly impacting crop production and, consequently, your profits. This hits particularly hard in areas that are less favourable for farming, and there are many of these in Scotland.

    This industry is resilient. I am in awe of everyone in this room who contributes to our food security, our rural and island communities and the growth of the UK economy. But let me make one thing clear – this Government does not take your resilience and adaptability for granted.

    My own constituency of Midlothian is dotted with farms and farmers, many of whom I have had the pleasure of meeting both as I campaigned, and in my first proud months as their representative in Parliament.

    I know that there is no substitute for meeting people in the places they live and work, on their terms. I have carried this principle into my first months as a Minister in the Scotland Office. On one of my very first ministerial visits last year I met with Lucy and Pete Grewar, who own Sheriffton Farm in Perthshire.

    I was there to discuss their challenges in finding staff to help pick their broccoli, and made a promise to come back with a Home Office ministerial colleague to visit Scotland to hear about these issues directly. I was thrilled that we were able to do that earlier this week when alongside NFUS representatives, Seema Malhotra, the Minister for Migration and Citizenship, and I visited a soft fruit farm in Aberdeenshire.

    Whilst on the farm, Seema and I had further discussion with the owners and NFUS about the Seasonal Workers; Visa scheme and how labour shortages impact their work, but also the need to drive economic growth and encourage domestic workers to take up these vital jobs.

    I also had similarly frank and productive conversations with crofters on the Isle of Lewis. We will continue to engage with you, and I will continue to invite my UK Government colleagues to come up to Scotland and hear directly from rural communities what they need.

    I value every single one of these visits as it gives me the opportunity to really hear from the people who are directly impacted by Government policy, and who also help us achieve our goals of food security, sustainability, Net Zero, economic growth, and countless others.

    And I just want to reassure you that I really listen in these conversations and I do, personally, read everything that I am sent in follow up. So if you have evidence you want me to read, stories you want me to hear or places you want me to visit I give you my word: you will always get a hearing from me. Just be in touch.

    Now there are four areas of UK Government policy that I want to focus on in the time I have left.

    Firstly, inheritance tax.

    This Government was forced to make many difficult decisions when it came into power due to our own challenging inheritance of the £22 billion financial black hole in public finances left by the previous Conservative administration.

    We could have just ignored it. We could have kicked the problem down the road. But when we stood for election we promised to take the hard choices head on. We needed to act.

    I know many of you in this room don’t agree with how we responded and feel let down. So I want you to hear in my own words, as someone who represents farmers right across my own constituency, why the Government made this decision.

    Under the current system, APR and BPR have granted 100% relief since 1992 on business and agricultural assets. However, this is heavily skewed towards the very wealthiest landowners and business owners.

    According to the latest data from HMRC, 40% of agricultural property relief is claimed by just 7% of UK estates making claims. That means that just 117 estates across the UK were claiming over £200 million of relief in 2021-22.

    Unfortunately, we also know that the reality today is that buying agricultural land is one of the most well-known ways to avoid inheritance tax.

    This has artificially inflated the price of farmland, locking younger farmers out of the market.

    None of this is either fair or sustainable. That is why we are reforming how agricultural and business property relief work. From April 2026, relief will be targeted in a way that still maintains significant tax relief while supporting the public finances, and protecting working people.

    I would like to thank Martin and his colleagues at NFUS for their helpful engagement with myself and the Secretary of State for Scotland, Ian Murray, on this issue. I am grateful for the dialogue we have had and will continue to have.

    We have had a disagreement, not a falling out – a difference of opinion on one question should not – must not – prevent us from talking about all the others. And talking is what we will continue to do. We will continue to engage with stakeholders in meetings like this and on farms, and we will continue to strengthen relations with the Scottish Government, respecting the fact that agriculture policy is devolved. 

    That’s why in the coming months the Scotland Office will host a food and farming roundtable where we will invite the industry and the Scottish Government to sit together and discuss these important issues. This will allow us to keep these conversations going.

    Now I would like to further address the devolved agriculture budget.

    I appreciate the vital role Scottish agriculture plays in rural communities and the economy in Scotland. The Secretary of State for Scotland wrote to the Defra Minister for Rural Affairs and Food Security outlining this prior to the Autumn Budget.

    And at the Budget, Defra announced the biggest budget for sustainable food production and nature recovery in history. This included £620m for Scotland for 2025-2026, baselined from last year. This is an above-population share, and the ringfence was removed to respect the devolution settlement – meaning it is for the Scottish Government to determine how they support farmers and rural communities with the public services they rely on.

    But we did not stop there. We wanted to address the issues rural communities face holistically – and the Autumn Budget delivered on that.

    The fuel duty freeze extension means that rural communities who depend on cars, vans and tractors will be able to save more of their income.

    The Budget also gave the go ahead for rural growth deals in Scotland, such as for Argyll and Bute, creating hundreds of jobs and countless opportunities for rural and island communities there.

    We recognise how important it is for rural areas, especially in Scotland, to have the same broadband connectivity and opportunities as the rest of the UK, so we announced in the Budget last year an additional £500 million for Project Gigabit and the Shared Rural Network.

    Next I would like to touch on seasonal workers, referred to earlier.

    While we are not currently considering a Scotland-only visa, this Government knows how important securing the right workforce is to the agri-food chain. This includes skilled jobs such as butchers and vets and temporary roles, such as seasonal horticulture harvesting and poultry processing jobs.

    Underlining the government’s commitment to the horticultural and poultry industry, the Seasonal Worker visa route has been confirmed for 2025, with a total of 43,000 Seasonal Worker visas available for horticulture and 2,000 for poultry next year.

    This will help the sector secure the labour and skills needed to bring high quality British produce, including strawberries, rhubarb, turkey and daffodils to market.

    In addition, Defra published the 2023 Seasonal Workers Survey report on 21 October 2024. 

    The survey showed that the vast majority of respondents reported a positive experience from their time in the UK and 95% expressed a desire to return. This excellent feedback reflects so well on farmers and the vibrancy of rural communities.

    When I visited a Perthshire farm weeks into office, the clearest thing I heard was that Scotland’s farmers wanted a hearing at the Home Office – I promised then that I’d try to bring a Home Office minister to Scotland to hear from farmers directly and that’s a promise kept. Just two days ago I was in a farm in Aberdeenshire with Seema Malhotra, the immigration minister, hearing about how seasonal worker rules could be made to work better for you. The door is always open and so are our minds – we want an ongoing relationship with a practical focus on getting things done.

    -And finally, just let me say something on future trade deals.

    Supporting farmers will always be a priority for this Government. We have been clear we will protect farmers from being undercut by low welfare and low standards in trade deals.

    We will continue to maintain our existing high standards for animal Health and food hygiene, ensuring that imported products comply with our domestic standards and import requirements.

    We are committed to developing a trade strategy that will support economic growth and promote the highest standards of food production.

    The UK has a network of sixteen agrifood and drink attachés around the world who break down market access barriers, create new export opportunities and protect existing trade. Our attachés work closely with Scottish Development International’s global network on delivering market access / export opportunities for Scotland.

    Promoting Scotland internationally through initiatives such as Brand Scotland – a new initiative led by my department backed by three quarters of a million pounds of funding – is a priority for this Government, and these export opportunities are an excellent way to do that.

    In addition, we will seek to negotiate a Sanitary and Phytosanitary agreement with the EU to reduce trade frictions, boost trade and deliver significant benefits on both sides.

    I want to reiterate my commitment to you that this Government will do everything it can to support you, listen to you and advocate for you, to ensure we not only protect but also maximise the potential of this incredible industry.

    Let me end by saying that it has been the honour of my life to serve as MP of Midlothian since July of last year, so I am here today telling you that I will fight for you as a Minister, but I also understand the views of my constituents. Many of them have the same concerns as you.

    Many of them are either farmers themselves, or live in a rural community where farming is a crucial backbone.

    And I want to assure you I understand your importance is more than the material benefits you bring – important though that is. Alongside farming, tourism and heritage are also in my portfolio. I treasure Scotland’s vibrant national museums, and the National Museum of Rural Life is no different – it’s a beautiful, living tribute to Scottish farming and rural life.

    Every time I visit, I can feel the importance of farming to the Scottish identity. I know that all you want is to be able to do what you are good at, what you love.

    It is my duty and that of this Government to ensure you have everything you need to do that, to protect your place in this extremely important endeavour. I promise you we will not let you down. It’s just too important.

    I am going to take a few questions now. Thank you to NFUS for inviting me here today, and to all of you for coming along. I wish you the very best for the rest of your conference.

    Updates to this page

    Published 6 February 2025

    MIL OSI United Kingdom

  • MIL-OSI NGOs: sched pub test 2

    Source: Médecins Sans Frontières –

    Access Campaign

    We set up the MSF Access Campaign in 1999 to push for access to, and the development of, life-saving and life-prolonging medicines, diagnostic tests and vaccines for people in our programmes and beyond.

    GO TO SITE

    CRASH

    Based in Paris, CRASH conducts and directs studies and analysis of MSF actions. They participate in internal training sessions and assessment missions in the field.

    GO TO SITE

    UREPH

    Based in Geneva, UREPH (or Research Unit) aims to improve the way MSF projects are implemented in the field and to participate in critical thinking on humanitarian and medical action.

    GO TO SITE

    ARHP

    Based in Barcelona, ARHP documents and reflects on the operational challenges and dilemmas faced by the MSF field teams.

    GO TO SITE

    MSF Analysis

    Based in Brussels, MSF Analysis intends to stimulate reflection and debate on humanitarian topics organised around the themes of migration, refugees, aid access, health policy and the environment in which aid operates.

    GO TO SITE

    MSF Supply

    This logistical and supply centre in Brussels provides storage of and delivers medical equipment, logistics and drugs for international purchases for MSF missions.

    GO TO SITE

    MSF Logistique

    This supply and logistics centre in Bordeaux, France, provides warehousing and delivery of medical equipment, logistics and drugs for international purchases for MSF missions.

    GO TO SITE

    Amsterdam Procurement Unit

    This logistical centre in Amsterdam purchases, tests, and stores equipment including vehicles, communications material, power supplies, water-processing facilities and nutritional supplements.

    GO TO SITE

    Brazilian Medical Unit

    BRAMU specialises in neglected tropical diseases, such as dengue and Chagas, and other infectious diseases. This medical unit is based in Rio de Janeiro, Brazil.

    GO TO SITE

    MSF Medical Guidelines

    Our medical guidelines are based on scientific data collected from MSF’s experiences, the World Health Organization (WHO), other renowned international medical institutions, and medical and scientific journals.

    GO TO SITE

    Epicentre

    Providing epidemiological expertise to underpin our operations, conducting research and training to support our goal of providing medical aid in areas where people are affected by conflict, epidemics, disasters, or excluded from health care.

    GO TO SITE

    Evaluation Units

    Evaluation Units have been established in Vienna, Stockholm, and Paris, assessing the potential and limitations of medical humanitarian action, thereby enhancing the effectiveness of our medical humanitarian work.

    GO TO SITE

    LGBTQI+ Inclusion in Health Settings

    MSF works with LGBTQI+ populations in many settings over the last 25-30 years. LGBTQI+ people face healthcare disparities with limited access to care and higher disease rates than the general population.

    GO TO SITE

    LUXOR

    The Luxembourg Operational Research (LuxOR) unit coordinates field research projects and operational research training, and provides support for documentation activities and routine data collection.

    GO TO SITE

    Intersectional Benchmarking Unit

    The Intersectional Benchmarking Unit collects and analyses data about local labour markets in all locations where MSF employs people.

    GO TO SITE

    MSF Academy for Healthcare

    To upskill and provide training to locally-hired MSF staff in several countries, MSF has created the MSF Academy for Healthcare.

    GO TO SITE

    Humanitarian Law

    This Guide explains the terms, concepts, and rules of humanitarian law in accessible and reader-friendly alphabetical entries.

    GO TO SITE

    MSF Paediatric Days

    The MSF Paediatric Days is an event for paediatric field staff, policy makers and academia to exchange ideas, align efforts, inspire and share frontline research to advance urgent paediatric issues of direct concern for the humanitarian field.

    GO TO SITE

    MSF Foundation

    The MSF Foundation aims to create a fertile arena for logistics and medical knowledge-sharing to meet the needs of MSF and the humanitarian sector as a whole.

    GO TO SITE

    DNDi

    A collaborative, patients’ needs-driven, non-profit drug research and development organisation that is developing new treatments for neglected diseases, founded in 2003 by seven organisations from around the world.

    GO TO SITE

    MSF Science Portal

    Our digital portal dedicated to sharing the latest medical evidence from our humanitarian activities around the globe.

    GO TO SITE

    Noma

    Noma is a preventable and treatable neglected disease, but 90 per cent of people will die within the first two weeks of infection if they do not receive treatment.

    GO TO SITE

    TIC

    The TIC is aiming to change how MSF works to better meet the evolving needs of our patients.

    GO TO SITE

    Telemedicine

    MSF’s telemedicine hub aims to overcome geographic barriers for equitable, accessible, and quality patient care.

    GO TO SITE

    Sweden Innovation Unit

    Launched in 2012, the MSF Sweden Innovation Unit deploys a human-centered approach for promoting a culture of innovation within MSF.

    GO TO SITE

    MIL OSI NGO

  • MIL-OSI USA: 2025-15 AG NEWS RELEASE – ATTORNEY GENERAL LOPEZ AND 13 OTHER ATTORNEYS GENERAL ISSUE JOINT STATEMENT ON PROTECTING ACCESS TO GENDER-AFFIRMING CARE

    Source: US State of Hawaii

    2025-15 AG NEWS RELEASE – ATTORNEY GENERAL LOPEZ AND 13 OTHER ATTORNEYS GENERAL ISSUE JOINT STATEMENT ON PROTECTING ACCESS TO GENDER-AFFIRMING CARE

    Posted on Feb 5, 2025 in Latest Department News, Newsroom

     

    STATE OF HAWAIʻI

    KA MOKU ʻĀINA O HAWAIʻI

     

    DEPARTMENT OF THE ATTORNEY GENERAL

    KA ʻOIHANA O KA LOIO KUHINA

     

    JOSH GREEN, M.D.
    GOVERNOR

    KE KIAʻĀINA

     

    ANNE LOPEZ

    ATTORNEY GENERAL

    LOIO KUHINA

     

     

    ATTORNEY GENERAL LOPEZ AND 13 OTHER ATTORNEYS GENERAL ISSUE JOINT STATEMENT ON PROTECTING ACCESS TO GENDER-AFFIRMING CARE

     

    News Release 2025-15

     

    FOR IMMEDIATE RELEASE                                                       

    February 4, 2025

     

    HONOLULU –Attorney General Anne Lopez today joined a coalition of 14 attorneys general to reaffirm their commitment to protecting access to gender-affirming care in the face of the Trump Administration’s recent Executive Order. The coalition released the following statement: 

     

    “As state attorneys general, we stand firmly in support of healthcare policies that respect the dignity and rights of all people. Health care decisions should be made by patients, families and doctors, not by a politician trying to restrict freedoms. Gender-affirming care is essential, lifesaving medical treatment that supports individuals in living as their authentic selves.

     

    The Trump Administration’s recent Executive Order is wrong on the science and the law. Despite what the Trump Administration has suggested, there is no connection between “female genital mutilation” and gender-affirming care, and no federal law makes gender-affirming care unlawful. President Trump cannot change that by Executive Order.  

     

    Last week, attorneys general secured a critical win from a federal court that directed the federal government to resume funding that had been frozen by the Trump Administration. In response to the court’s order, the Department of Justice has sent a notice stating that “federal agencies cannot pause, freeze, impede, block, cancel, or terminate any awards or obligations on the basis of the OMB memo, or on the basis of the President’s recently issued Executive Orders.” This means that federal funding to institutions that provide gender-affirming care continues to be available, irrespective of President Trump’s recent Executive Order. If the federal administration takes additional action to impede this critical funding, we will not hesitate to take further legal action. 

     

    State attorneys general will continue to enforce state laws that provide access to gender-affirming care, in states where such enforcement authority exists, and we will challenge any unlawful effort by the Trump Administration to restrict access to it in our jurisdictions.” 

     

    Joining Attorney General Lopez in issuing this statement are the attorneys general of California, Colorado, Connecticut, Delaware, Illinois, Maine, Maryland, Massachusetts, New Jersey, New York, Nevada, Rhode Island, Vermont and Wisconsin.

     

    # # #

     

    Media contacts:

    Dave Day

    Special Assistant to the Attorney General

    Office: 808-586-1284                                                  

    Email: [email protected]        

    Web: http://ag.hawaii.gov

     

    Toni Schwartz
    Public Information Officer
    Hawai‘i Department of the Attorney General
    Office:
    808-586-1252
    Cell: 808-379-9249
    Email:
    [email protected] 

    Web: http://ag.hawaii.gov

     

    MIL OSI USA News